People

Nandita Shangari holds the source-published role of Managing Director, Venture within RA Capital Management’s Healthcare group. The individual directory reports joining in2023; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Toronto Canada. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Abigail Schmitz holds the source-published role of Senior Associate, Corporate Development within RA Capital Management’s Healthcare group. The individual directory reports joining in2023; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Alabama, University of Chicago. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Jonathan Pritz holds the source-published role of Investment Director, Venture within RA Capital Management’s Healthcare group. The individual directory reports joining in2018; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Florida, Harvard University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Breanna O’Reilly holds the source-published role of Analyst within RA Capital Management’s Healthcare group. The individual directory reports joining in2023; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Rochester, Boston University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Fuad Naser holds the source-published role of Analyst within RA Capital Management’s Healthcare group. The individual directory reports joining in2021; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Washington University St. Louis. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Emily Minkow holds the source-published role of Managing Director, Venture within RA Capital Management’s Healthcare group. The individual directory reports joining in2022; a precise appointment day is not available. Published academic qualifications: MBA. Universities identified in the own biography: Princeton University, Harvard Business School. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Alex Miller holds the source-published role of Senior Associate, Venture within RA Capital Management’s Healthcare group. The individual directory reports joining in2023; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Harvard University, Harvard-MIT Health Sciences and Technology Program. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. RA bioengineering/medicalphysics PhD scientist is distinct from Arize revenueoperations executive and S2G AlexandraMiller assistant. Specific personal checks are not inferred from affiliation.

Megan Lipcsey holds the source-published role of Investment Director within RA Capital Management’s Healthcare group. The individual directory reports joining in2022; a precise appointment day is not available. Published academic qualifications: MD , MBA. Universities identified in the own biography: University of Florida, Tulane University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Anurag Kondapalli holds the source-published role of Principal within RA Capital Management’s Healthcare group. The individual directory reports joining in2021; a precise appointment day is not available. Published academic qualifications: BSE , BS. Universities identified in the own biography: Duke University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Julie Gupta holds the source-published role of Senior Associate, Corporate Development, Venture within RA Capital Management’s Healthcare group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Barnard College of Columbia University, University of Michigan. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Maxwell DeNies holds the source-published role of Analyst within RA Capital Management’s Healthcare group. The individual directory reports joining in2020; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: State University of New York at Fredonia, University of Michigan. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Tyler Carney holds the source-published role of Associate, Structured Capital within RA Capital Management’s Healthcare group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: BA. Universities identified in the own biography: Yale University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Tess Cameron holds the source-published role of Managing Director, Venture within RA Capital Management’s Healthcare group. The individual directory reports joining in2020; a precise appointment day is not available. Published academic qualifications: BA. Universities identified in the own biography: University of Toronto Canada. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Davis Buchanan holds the source-published role of Associate, Structured Capital within RA Capital Management’s Healthcare group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: BA. Universities identified in the own biography: University of Pennsylvania. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Sahiba Baveja holds the source-published role of Associate, Structured Capital within RA Capital Management’s Healthcare group. The individual directory reports joining in2025; a precise appointment day is not available. Published academic qualifications: BSc. Universities identified in the own biography: University of Pennsylvania. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Peter Balogh holds the source-published role of Analyst within RA Capital Management’s Healthcare group. The individual directory reports joining in2020; a precise appointment day is not available. Published academic qualifications: BS. Universities identified in the own biography: University of North Carolina Chapel Hill. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Adam Kaye holds the source-published role of Senior Managing Director and Partner, Structured Capital within RA Capital Management’s Healthcare group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: MS , BBA. Universities identified in the own biography: New York University, Emory University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Zefralyn Guerrero is published by GV as Administrative Business Partner. Joined GV in2023 in San Francisco office operations and now serves as administrative business partner. Earlier worked in patient-care coordination and Google workplace operations.

Zal Bhathena is published by GV as Engineering Partner. An engineering partner specializing in data infrastructure. Previously built systems at Two Sigma, Bloomberg and Spotify and now helps portfolio teams work with complex datasets.

Zach Brauer is published by GV as Senior Finance Partner. Advises portfolio companies on finance, including budgeting, finance-team development, acquisitions and fundraising. His work also supports diligence for life-sciences investments.

Yeji Han is published by GV as Legal Counsel. Provides legal counsel to GV. Previously advised startups and venture investors at Gunderson Dettmer; studied economics at Chicago and law at Berkeley.

Winnie Kimaiga is published by GV as Executive Business Partner. An executive business partner with earlier senior administrative experience at the Broad Institute. Holds a management degree from Boston University.

Vidu Shanmugarajah is published by GV as General Partner. A London general partner backing early technology companies. His investments include AI-video platform Synthesia and legal-AI company Lawhive.

Victoria Miller is published by GV as A/EBP Team Manager. Previously supported TPG Special Situations Partners and worked in boutique private equity. Studied business management and writing at Gettysburg College.

Tom Hulme is published by GV as Managing Partner. Heads GV’s European practice and jointly leads technology investing. Previously led design and startup initiatives at IDEO, founded OpenIDEO and Magnom, and managed sports-car manufacturer Marcos.

Teni Ajayi is published by GV as Executive Business Partner. Joined GV in2021 following executive support at Stack Overflow and goTenna. Earlier worked in fashion and beauty merchandising and studied retail and product development at Florida State University.

Jeremy Lack holds the source-published role of Partner within RA Capital Management’s Healthcare group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: DPhil. Universities identified in the own biography: Cornell University, University of Oxford. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Josh Resnick holds the source-published role of Partner within RA Capital Management’s Healthcare group. The individual directory reports joining in2018; a precise appointment day is not available. Published academic qualifications: MD. Universities identified in the own biography: Williams College, University of Pennsylvania. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Derek DiRocco holds the source-published role of Partner within RA Capital Management’s Healthcare group. The individual directory reports joining in2013; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Holy Cross College, University of Washington. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Matt Hammond holds the source-published role of Partner within RA Capital Management’s Healthcare group. The individual directory reports joining in2014; a precise appointment day is not available. Published academic qualifications: PhD, MBA. Universities identified in the own biography: University of Georgia, University of Connecticut. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Jake Simson holds the source-published role of Partner within RA Capital Management’s Healthcare group. The individual directory reports joining in2013; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Massachusetts Institute of Technology, Johns Hopkins University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Zach Scheiner holds the source-published role of Partner within RA Capital Management’s Healthcare group. The individual directory reports joining in2015; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Yale University, University of Washington. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Rajeev Shah holds the source-published role of Managing Partner within RA Capital Management’s Healthcare group. The individual directory reports joining in2004; a precise appointment day is not available. Published academic qualifications: BA. Universities identified in the own biography: Cornell University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Stefany Zelaya is published by GV as Executive Business Partner. Joined GV in2020 after supporting Lyft’s public-policy executives. Previously supported YouTube and Google Cloud recruiting teams; studied finance at San Francisco State University.

Sridhar Ramaswamy is published by GV as Entrepreneur in Residence & Venture Partner. A physician-scientist and venture partner building new medical companies. His entrepreneur-in-residence role focuses on translating complex therapeutic and diagnostic science into businesses; distinct from Snowflake’s same-name CEO.

Sierra Warner is published by GV as Chief People Officer. Leads GV’s people strategy. Previously advised Alphabet businesses on HR and worked in Google communications; joined GV in2019 and studied communications at Santa Clara University.

Sherry Chao is published by GV as Partner. A life-sciences investor with prior Goldman Sachs private-equity and Broad Institute immunology experience. Holds a Harvard computational-biology doctorate and MBA.

Paul Touya works on fund performance, investor reporting and capital calls at Elaia. His earlier experience includes investment-fund auditing at PwC and securitization work at Crédit Agricole CIB.

Paul Jumentier supports responsible investing and environmental reporting at Elaia. He previously worked on emissions reporting and decarbonization at Groupe iliad.

Sandra Gallet supports the leadership teams of Elaia and Lazard Elaia Capital with schedules, meetings and office coordination. Her earlier work includes executive assistance and office management at XAnge and operations at a multi-family office. The possible alias to native Sandra Benacquista has not been established by an exact primary identity bridge.

Nicolas Domenech works on Elaia’s strategic projects, fundraising and portfolio matters as chief of staff to Xavier Lazarus. He previously worked in corporate development at Doctolib and in mergers and acquisitions.

Louise Albinet coordinates executive schedules, travel, events and office operations at Elaia. She previously worked on commercial and project coordination at Defiluxe.

Mattéo Ponce researches frontier technologies and supports Elaia’s deep-tech deal sourcing and diligence. His earlier work includes aerospace and defence startup programs at Starburst and microgrid engineering at ENGIE.

Taylor Chartier founded Modicus Prime after engineering and data-science work in pharmaceutical manufacturing at Shire and Bayer. She works on AI assurance and governance in regulated life sciences and co-authored industry implementation guidance published by ISPE and BioPhorum.

Scott Davis is published by GV as Venture Partner. A Dartmouth biomedical-engineering professor and part-time life-sciences venture partner. Works on imaging, diagnostics and drug-delivery technology; holds physics, engineering and doctoral qualifications.

Scott Biller is published by GV as Executive Venture Partner. A biotechnology executive and scientific adviser. Previously served as Agios chief scientific officer and helped develop medicines targeting metabolic pathways; current GV title is executive venture partner.

Sangeen Zeb is published by GV as General Partner. Invests in AI companies including Harvey, OpenEvidence and Vercel. Earlier invested at Founders Circle Capital; his own current biography also identifies investments in Safe Superintelligence and Thinking Machines.

Sam McCauley is published by GV as Engineering Partner. An engineer specializing in systems performance and AI infrastructure. Previously worked on Google Cloud Run and led serverless-AI engineering with Google DeepMind collaborations.

Sal Diaz is published by GV as Finance Manager. Works on financial reporting and accounting. Earlier served in PwC’s venture-capital and life-sciences assurance practice and studied accounting at California State University East Bay.

Ryan Spiers is published by GV as Associate General Counsel. Advises GV’s life-sciences investors on legal transactions. Previously worked at Cooley on venture financings, acquisitions and securities matters; earned law degrees at Duke.

Roni Hiranand is published by GV as Principal. A London principal investing across enterprise and frontier technology. Previously invested through Ant Financial’s venture organization; his own biography describes international technology-market experience.

Robin Teng is published by GV as Senior Controller. Oversees fund accounting and portfolio reporting. Earlier worked at Sequoia Capital and Ernst & Young; holds UCLA business-economics and Notre Dame accounting degrees.

Rob Wu is published by GV as Executive Business Partner. An executive business partner with startup operations and entrepreneurial experience. Helped establish Underscore VC’s internal operations and relationships and previously worked as a music-industry entrepreneur.

Rishi Modi is published by GV as Associate. Invests in AI applications and infrastructure from GV’s San Francisco office. Earlier worked at J.P. Morgan and with Menlo Ventures, CyCognito and other technology-investment organizations; studied business and data science at Berkeley.

Rhys Hughes is published by GV as Executive Talent Partner. Leads executive talent initiatives and helps portfolio companies build leadership teams. His work involves recruiting networks and advice on organizational scale.

Nicole Radell is published by GV as A/EBP Team Manager. Joined GV in2020 after supporting leaders at SYLVAIN and Saatchi & Saatchi. Earlier worked with People magazine and Universal Pictures executives; studied film and television at USC.

Nicole Gaudelli is published by GV as Entrepreneur in Residence. An entrepreneur in residence working on precision genetic medicines. Her scientific background connects chemistry and biology; earned a Johns Hopkins chemistry doctorate.

Nicole Doherty is published by GV as Executive Business Partner. An executive-support professional whose earlier employers include LendUp, Nest, Dropcam and Bain. Studied communications at UC Davis.

Nate Amchan is published by GV as Senior Manager, Portfolio Advisor. Advises on portfolio finance, particularly public equities. Previously held finance roles at Google and worked at PwC; studied accounting and finance at Ohio State and is a CFA charterholder.

Natalie Schwartz is published by GV as Head of Marketing. Leads GV’s marketing strategy across publishing, events and social channels. Her previous marketing work includes Google, Etsy, Airbnb and Canva.

Natalie Sanchez is published by GV as Assistant Controller. Supports portfolio reporting and fund accounting. Earlier worked at Sequoia Capital and PwC, auditing life-science and venture clients; studied finance at Santa Clara University.

Mounisha Anumolu is published by GV as Associate. A New York investor working across AI technologies and funding stages. Earlier worked on enterprise-software transactions at Goldman Sachs and researched financial technology at Brookings.

Mojca Skoberne is published by GV as Entrepreneur in Residence. An entrepreneur in residence developing companies around immune-system biology. Her work focuses on how immunity interacts with tissues and can be directed toward new treatments.

Mim West is published by GV as Executive Business Partner. Joined GV in2023 after senior executive support in London investment organizations. Her background spans financial services and property; studied film and media at Birkbeck.

Michael Parker is published by GV as Executive Business Partner. Joined GV in2025 after supporting Roivant Sciences’ investment team. Earlier supported leaders at a film-and-television investment startup and studied business at Miami University of Ohio.

Michael McBride is published by GV as General Partner. A technology executive and investor with experience leading product, sales, marketing and business-development organizations. Studied mechanical engineering at Stanford and brings an engineering approach to company growth.

Megan Klein is published by GV as Executive Business Partner. Joined GV in2025 after supporting Lunar Energy’s CEO. Her earlier experience includes executive, workplace and security operations at CSI Electrical Contractors and engineering support at Pinger.

McKenzie Furber is published by GV as Talent Partner. Advises founders on leadership hiring and organizational growth. Earlier spent more than seven years in executive search at Kindred Partners.

Mandy Stolpa is published by GV as Partner & Head of Communications. Leads GV’s communications and advises founders on public relations. Her experience covers company positioning, financial communications and reputation management.

Maggie Moran is published by GV as Executive Business Partner. Supports Cambridge-office events and executive operations. Previously worked with Google Cloud Health and Verily teams and managed hospitality events in Washington, D.C.

Luna Schmid is published by GV as Partner. A London-based technology investor. Previously worked at Summit Partners, SoftBank’s Vision Fund and Warburg Pincus, after starting in Morgan Stanley investment banking.

Luke Elder is published by GV as Sr. Legal Counsel. Previously advised venture investors and companies at Wilson Sonsini on financings, acquisitions and governance. Holds Berkeley political-science and University of Chicago law degrees.

Lily Johnson is published by GV as Executive Business Partner. Supports GV’s operations team after six years building Pear VC’s operating infrastructure, people programs and community. Previously supported a real-estate company’s CEO.

Krishna Yeshwant is published by GV as Managing Partner. A physician and computer scientist who leads healthcare investing as managing partner. Earned Harvard MD and MBA degrees, practiced internal medicine at Brigham and Women’s Hospital and joined Google in2008.

Kim Burr is published by GV as Chief Financial Officer. Leads GV’s finance organization. Earlier worked at Sequoia Capital and BlueRun Ventures, began in Deloitte’s audit practice and studied business economics at UCLA.

Kelsey Dowling is published by GV as Assistant Controller. Previously analyzed finances across Alphabet X’s startup projects. Studied environmental science at UCLA and now works in GV’s accounting organization.

Karthik Ardhanareeswaran is published by GV as Partner. A San Francisco life-sciences investor who previously developed quantitative trading strategies at D.E. Shaw. Earlier researched stem-cell biology and neurodevelopmental disorders at Yale, where he studied molecular and developmental biology.

Karen Ku is published by GV as Legal Operations Specialist. Joined GV’s legal operations team in2022 after working at Cooley on emerging-company and venture-capital matters. Her role supports transactions and the firm’s operating processes.

Kaitlin Shavey is published by GV as Events Manager. Organizes GV’s events following event-program work at Pear VC. Earlier worked on large technology conferences through George P. Johnson.

KJ Sidberry is published by GV as Partner. A New York investor in early consumer businesses. Previously invested at Forerunner Ventures and worked in consulting at Accenture and Boston Consulting Group; studied computer science at Harvard.

John Bui is published by GV as Engineering Partner. Specializes in frontend engineering and product architecture. Previously developed Facebook and Oculus Android applications at Meta; holds a Brown computer-science degree.

Jessica Ashford is published by GV as Controller. Works on fund accounting and reporting. Her earlier experience includes Sequoia Capital, Standish Management and PwC; studied business administration at Cal Poly.

Issi Rozen is published by GV as General Partner. A biotechnology company builder and investor focused on new companies and early financings. Co-founded Verve Therapeutics and has held biotech strategy and business-development roles.

Irina Umansky is published by GV as Executive Business Partner. Supports GV’s legal and operating teams. Earlier helped run communications and culture at a molecular-testing startup and worked with Uber’s engineering organization.

Holly Heafey is published by GV as Executive Talent Researcher. Advises portfolio companies on executive recruiting and leadership networks. Previously spent more than seven years in executive research and recruiting at Confluent.

Helen Truong is published by GV as Executive Business Partner. Joined GV in2022 after supporting TPG Capital’s consumer investors. Her earlier career includes hospitality; studied hospitality management at San Jose State University.

Greg Schacht is published by GV as Sr. Financial Analyst. Handles financial analysis and reporting. Earlier audited venture funds at Frank, Rimerman and earned accounting degrees at Arizona State University.

Greg Dooley is published by GV as Engineering Partner. An engineering partner who previously built Google advertising infrastructure tools. Holds an MIT physics doctorate, with research in computational cosmology and statistical simulations.

Graham Hancock is published by GV as Content Partner. Leads GV’s digital publishing and media work, including its site and podcast. Earlier produced founder interviews and managed digital-media post-production at Discovery Digital Networks.

Gina Novak is published by GV as Controller. An accounting executive with earlier controller experience at Sequoia Capital. Began her career in Ernst & Young’s audit practice and studied accounting at Santa Clara University.

Gabriel Alatorre is published by GV as Engineering Partner. A full-stack engineer who joined GV in2024. Previously built Google Search and YouTube features, including AI educational-video tools, and worked on cloud storage at IBM Research.

Frédérique Dame is published by GV as General Partner. Invests in consumer technology after a career building technology products. She helped establish GV’s women’s-health investing effort and brings product-development experience to portfolio work.

Francy Troche is published by GV as Office Manager. Manages GV’s New York office, events and administrative operations. Joined in2024 after workplace and facilities responsibilities at Google.

Erik Nordlander is published by GV as General Partner. Invests in developer software, cloud systems and machine learning. He also leads GV’s technical team and New York operations, drawing on an engineering background.

Elizabeth Zeratsky is published by GV as Associate General Counsel. Advises GV’s digital investing practice on legal matters. Previously handled venture financings, securities transactions and acquisitions at Cooley; studied history at Stanford and law at Northwestern.

Elena Sakach is published by GV as Partner. Joined GV in2024 after investing across stages at Coatue. Focuses on AI applications, financial technology and infrastructure supporting enterprise adoption.

Dylan Sorman is published by GV as People Operations Program Manager. Runs people-operations programs after work at Google X and Gilead Sciences. His background includes people analytics, compensation, performance management and executive search.

David Schenkein is published by GV as General Partner. A hematologist and oncologist who leads GV’s life-sciences investing. Focus areas include medicines, diagnostics, devices and changes in care delivery.

David Reshef is published by GV as Venture Partner. A physician and computer scientist investing in machine learning, healthcare and biotechnology. His research explores structure in high-dimensional datasets and has appeared in scientific and statistics journals.

David Krane is published by GV as CEO & Managing Partner. Joined Google in2000 after working at Qualcomm and Apple, and led Google’s global communications and public affairs. Now oversees GV’s investing and global operations;2026 primary SEC filings confirm the exact manager’s CEO role.

Dave Munichiello is published by GV as Managing Partner. Leads GV’s technology investment practice across consumer, enterprise and frontier technology. His current managing-partner role emphasizes working with technical founders over the long term.

Danielle Lewis is published by GV as Executive Business Partner. Joined GV in2014 after healthcare-team executive support at TPG Capital. Previously worked at Highbridge Capital Management and earned a Pepperdine MBA.

Dan Lynch is published by GV as Executive Venture Partner. Previously served as ImClone CEO and CFO and advised companies through Third Rock Ventures. At GV he supports life-sciences founders as an executive venture partner.

Crystal Huang is published by GV as General Partner. Invests in enterprise software, infrastructure and AI, including developer-led businesses. Earlier invested at NEA and Notable Capital and worked in technology mergers and acquisitions at Blackstone.

Crystal Dela Cruz is published by GV as Executive Business Partner. Brings executive-support, project-management and client-service experience to GV. Earlier worked at Apple in customer service and small-business support.

Christina Kelleher is published by GV as Executive Business Partner. Joined GV in2011 after managing office and executive-support work at TOTH+Co. Earlier experience includes event organization and public relations.

Chris Urenda is published by GV as Head of Legal Operations. Oversees legal operations across investments and fund administration. Previously worked on corporate governance, securities and compliance at Google; studied at UC San Diego.

Chelsea Kunin is published by GV as Executive Business Partner. Joined GV in2022 following executive support at Thrasio and OpenView. Studied communications at the University of Maine with psychology and human-relations minors.

Cathy Friedman is published by GV as Executive Venture Partner. A healthcare, technology and finance executive who advises GV’s healthcare strategy. Her experience includes company governance, women’s health and access to care; executive venture partnership is distinguished from a core salaried investing title.

Caroline Walters is published by GV as Portfolio Operations Partner. Supports portfolio-company operations. Previously held transformation and chief-of-staff responsibilities at Quartet Health and worked in clinical research at New York Presbyterian Hospital.

Caleb Langlinais is published by GV as Financial Analyst. Works in accounting and portfolio reporting after venture-fund audit work at Frank, Rimerman. Studied accounting at Michigan State University.

Brendan Bulik-Sullivan is published by GV as General Partner. Invests in life sciences following research in statistical genetics and machine learning. Earlier developed immuno-oncology models at Gritstone Oncology and genetics methods at the Broad Institute.

Ben Robbins is published by GV as General Partner. A psychiatrist whose investing covers healthcare delivery and neuropsychiatric medicines. His mental-health portfolio includes Firsthand and Guidelight; current directory identifies him as general partner.

Araceli Pacheco is published by GV as Sr. Financial Analyst. Handles accounting and portfolio reporting. Earlier worked in Ernst & Young’s Houston assurance practice and earned a professional-accounting master’s degree at the University of Texas at Austin.

Amy Anton is published by GV as Talent Partner. Works on technical hiring, particularly AI researchers and engineers. Her earlier talent-acquisition career included McKinsey and Google, with responsibility for building Google Cloud AI teams.

Abi Joyce is published by GV as Executive Business Partner. Previously supported Mary Portas at the Portas consultancy and worked in business development at First State Investments. Joined GV in2020 after a career in executive and business support.

Mark Dubowitz leads the Foundation for Defense of Democracies and advises on national-security policy. His earlier career includes venture investing and technology management.

Stephen Kaplan co-founded Oaktree and later established family investment office Nalpak Capital. His subsequent work includes sports ownership, board service and private investment.

Michael Oren is a historian and former Israeli ambassador to the United States. His public-service background also includes parliamentary and ministerial roles.

Maya Scholnick supports Protego’s operations and staff welfare. Her background includes international professional experience, competitive football and studies in psychology and business administration.

Paz Lazar coordinates strategic initiatives and cross-functional operations at Protego. She brings startup financial-planning experience and operational-planning experience from government and military service.

Dalit Krainer advises on organizational growth, leadership and people strategy. Her earlier roles include chief human-resources officer at Checkmarx and HR leadership at Amdocs.

Nir Gilbert invests at Protego after working at JAL Ventures and in product management at Atera. He also served in air-force leadership and studied information systems and business administration.

Danielle Zettel manages relationships and communications with Protego’s limited partners and supports its events and founder ecosystem. Her background includes event planning and foreign-relations logistics.

Ben Moore develops Protego’s partnerships and portfolio support. His career spans partnerships at Meta, government international outreach and communications consulting.

Tal Kelman works on defense strategy at Protego. His military career included strategic planning, air-force leadership and command of air bases and flight-training programs.

Yoel Mazur brings finance leadership experience across technology companies, venture funds and private equity. His work has included fund formation, investment operations and wind-down processes.

Ziv Avtalion leads Protego’s technical due diligence. He previously led military digital-transformation and technology programs and founded strategic-technology consultancy 55 AIM.

Lee Moser co-founded Protego Ventures, bringing venture-investing and company-building experience from AnD and ProFound. Her earlier work includes serving as chief of staff to Israel’s ambassador in Washington and helping expand BlackRock in Israel.

Lital Leshem co-founded Protego Ventures and emergency-communications company Carbyne. Her earlier work includes defense, aviation and cybersecurity investing at Frontier Resource Group and military intelligence service.

Stephen Francis, who calls himself Steve Francis on his own website, states that he currently invests in startups at Proximity Ventures and advises executives on strategy and communications through Narrative Design. His own published contact uses the ProxVC.com firm domain. His earlier experience includes building Street FC, investing in and advising startups at JAY-Z’s Roc Nation, working at early-stage startups and discovering music at EMI. His primary page does not publish a COO or Head of Platform title; that precise title remains unverified rather than imported from secondary directories.

Santi White, professionally known as Santigold, is a singer and songwriter whose identity is confirmed by her label Warner Music and performing institution LA Phil. Delphi’s own financing announcement names Santigold with Olivia Wilde as representatives of investor Proximity Ventures. That transaction establishes an institutional investment affiliation without publishing her formal manager title, appointment date or continuing employment. Her artistic biography describes songwriting and executive production for Res and prior work with the band Stiffed; these activities are distinct from any personal investment.

Jason Mack is affiliated with New York Proximity through his own professional experience profile and the firm’s published employee list. His profile lists NYU School of Professional Studies education in2017–2018. The publicly accessible primary pages do not establish a precise current manager title or appointment date, so the recorded affiliation is qualified. Reposts about technology companies are not treated as verified investments or portfolio ownership.

Olivia Wilde is a co-founder of Proximity according to the firm’s own company profile, alongside Neil Sirni. Delphi’s own Series A announcement names her with Santigold in its Proximity Ventures investor attribution. Wilde is also a filmmaker and actor: Sundance’s 2026 programme identifies her as director and cast member of The Invite and cast member of I Want Your Sex. Her manager affiliation is distinct from any personal investment; no general-partner title or exact appointment date is inferred.

Sean Day is the principal published by Rock Health Capital, having previously worked on Rock Health’s consulting and research teams. His own biography describes operations-analysis work at Epic with population-health R&D leaders, a summa-cum-laude bioengineering degree from Union College, a technology-policy master’s from Cambridge and a Watson Fellowship studying technology, culture and physical-disability perspectives in several countries. His investment-team role is distinguished from former platform consulting responsibilities.

Neil Sirni is co-founder and general partner of New York multi-stage venture firm Proximity, according to his own professional profile. Primary SEC notices for Proximity Health I and Fifth Down I identify him as the individual managing member above Proximity Ventures Management Co., LLC and each vehicle’s managing member. A March6,2017 Roc Nation announcement filed with the SEC identifies his earlier role as Head of New Ventures, helping launch the ARRIVE startup platform. That prior platform and its investment history are separate from Proximity; no personal investment or current Roc Nation employment is inferred.

Dr Monique Smith is the healthcare executive, emergency physician, digital-health strategist and angel investor named as a Rock Health Capital adviser. Her own biography identifies her as founding executive director of Health DesignED at Emory and describes previous RockHealth.org design-and-innovation leadership, clinical innovation, advisory work and healthcare transformation. She holds Harvard BA/MD degrees and an LSE MSc. The nonprofit’s former equitable-design role is distinct from her published current capital advisory affiliation; no personal institutional check is inferred.

Keith W. Anderson is the adviser published by Rock Health Capital. His own biography describes his former Amwell CFO role, leading its IPO and pre-IPO financing, earlier healthcare-technology investment-banking work in New York and London, and EY audit/M&A experience. He studied accounting and theology at Notre Dame and earned an MBA at Michigan’s Ross School. His outside transactions are career context, not capital raised by Rock Health or personally allocated portfolio checks.

Hylton Kalvaria is an adviser named and pictured in Rock Health Capital’s current investment directory. Helix’s current leadership page identifies him as Chief Commercial Officer; its2024 appointment release describes earlier life-sciences leadership and prior roles at clinical-natural-language-processing startup Mendel AI, Verana Health, Flatiron Health and Genentech. Verana’s2021 issuer account gives his Duke bachelor’s and MBA background. This scoped Rock Health advisory role does not imply an executive fund job or a personal financing check.

Vikas Taneja is a BCG Advisor at B Capital. He is also a Managing Director and Senior Partner with The Boston Consulting Group and the global lead of BCG’s Growth Tech practice – serving fast growing technology companies around the world. Vikas is on the executive leadership team of BCG’s Technology, Media, and Telecom practice. Previously, Vikas led BCG’s Sales and Go-To-Market topic globally. Vikas works with B Capital portfolio companies to scale and leverage the partnership between BCG and B Capital. Vikas’s commercial focus has been on helping clients scale and grow profitably. He has led major programs to improve business performance through Digital Transformation, improving innovation, sales productivity, product portfolio improvements, process reengineering, and organization restructuring. Prior to joining BCG, Vikas worked at ARCH Technology Partners where he evaluated and helped commercialize new technologies emerging from University of Chicago’s academic labs and medical school. Vikas has also worked in the Information & Technology group at McKinsey & Co. Vikas received his MBA with Honors from the University of Chicago and holds a Bachelor of Arts and Sciences in Computer Systems Engineering and Economics from Stanford University Vikas is on the Boston Advisory Board for Pratham, an India-based organization that has worked with over 4 million children to help them achieve literacy and basic mathematics skills. The BCG Advisors are not partners or employees of B Capital or its affiliates, but rather BCG employees who provide consulting services to B Capital, certain B Capital funds, and/or their portfolio companies as part of B Capital’s strategic partnership with BCG. BCG does not provide investment advice to or participate in the investment decision making of B Capital or any of its funds, and BCG is not involved in the day-to-day operations or management of B Capital. This affiliation is an external consulting role: BCG advisers are not B Capital employees or partners and do not provide investment advice, participate in fund investment decisions or manage the firm.

Mr. Lesser serves as Vice Chair, Climate & Sustainability and a Senior Advisor at B Capital. Additionally, Mr. Lesser is Global Chair of BCG and has more than 35 years of experience engaging with CEOs, boards of directors and senior leaders on critical topics, including climate and sustainability. He served as BCG’s CEO from 2013 to 2021, a period of exceptional growth for the firm and during which he launched the BCG Center for Climate & Sustainability. Mr. Lesser also serves as Chief Advisor to the World Economic Forum’s Alliance of CEO Climate Leaders. Prior to joining BCG, he worked in product development at Procter & Gamble. Mr. Lesser has an MBA from Harvard Business School and a B.S. in chemical engineering from the University of Michigan. Mr. Lesser is based in New York. Rich Lesser is not an employee of B Capital or its affiliates, but rather a BCG employee who acts as an independent senior advisor to B Capital and its executive leadership on certain strategic matters. As one of B Capital’s advisors, Rich is not part of B Capital’s management team, does not manage any B Capital employees, and does not (i) serve on any B Capital fund investment committees nor vote on any specific investment decisions or (ii) otherwise provide investment advice to B Capital on any investment strategy. This affiliation is an external consulting role: BCG advisers are not B Capital employees or partners and do not provide investment advice, participate in fund investment decisions or manage the firm.

Zayar is a seasoned IT professional with over 10 years in operations and infrastructure management. As a Senior Manager at B Capital, he supports global IT operations and focuses on improving user experience and technical support across diverse teams and regions. Before B Capital, he managed IT operations for CJ International Asia across SEA regions. Prior to that he spent 5 years at Micron Technology as an IT Operation Engineer and Database Administrator. He began his career at Singtel, supporting 3G/4G network integration and mobile operations. He holds Bachelor of Science in Electronics Engineering from Singapore University of Social Sciences.

Yuanyuan is a Finance Director in B Capital Group’s Beijing office, where she focuses on developing B Capital Group’s China team and investments. Yuanyuan has a BA in Financial Accounting from the University of Wales, UK. She has 13-years working experience in accounting field. She joins B Capital from Baidu Ventures, where she led their financial department. Prior to that, she was the Finance Director at Ceyuan Ventures. Initially, she focused on the early stage of investment in mainly TMT, healthcare technology and AI before shifting focus toward the later stages of investment.

Vicki is joining B Capital Group as a Senior Finance Manager, focusing on the management company team. Vicki has over 20 years of various accounting experience, in both the private and public sector, with heavy focus on FP&A. Vicki earned a BA in Business Administration and Accounting from Flagler College and is an active licensed CPA (FL). Vicki, her husband William and two daughters live in Oklahoma.

Tyron is a Principal in B Capital Group’s Hong Kong office and focuses on growth investments in China. Previously, Tyron spent 7 years with Temasek’s China and global teams looking at growth investments opportunities, covering sub-sectors including marketplaces, O2O, enterprise software as well as digital media. Tyron holds a bachelor’s degree from Shanghai Jiao Tong University and a master’s degree from Peking University. Tyron likes gym, scuba diving and making short videos in his spare time

Bill Evans is the founder and General Partner of Rock Health Capital and founder/chairman of the related Rock Health Advisory business. The26March2026 SEC FormADV names the investment adviser’s managing member William Oliver Evans, CRD6756383; its matching Rock Health business and fund roles support this legal/public-name identity. His own biography describes Roche Diagnostics work launching the Navify oncology decision-support unit, prior Genentech leadership, an economics degree from Harvard, Goldman Sachs experience and subsequent software-engineering work. He is distinct from the existing Dexory sales director named Bill Evans.

Tim is a Business Intelligence Manager, based in Singapore. He believes the key is to translate insights from data into actionable business goals that can make an impact. Tim joined B Capital from PayPal, where he was part of a global analytics team that enabled sales operations to make data-driven decisions. Prior to that, he led analytics at a large healthcare company in New York, where he established, managed, and expanded their business intelligence capabilities. He also spent time quantitatively assessing the impact of NGO projects in Rwanda and the Philippines. Tim holds a bachelor’s in Economics from the National University of Singapore and a master’s in International & Development Economics from the University of San Francisco. He spent the last 10 years in San Francisco and New York, and recently moved back to Singapore. On his days off, he enjoys scuba diving, walks with his golden retriever, and single-malt scotch with good friends.

Taylor Horty is a Director of Capital Formation at B Capital, where she partners with the Investor Relations team on fundraising across the firm’s global platform, bringing a decade of experience building relationships with family offices and institutional investors. Prior to joining B Capital, Taylor spent over seven years at Sagard, leading single and multi-family office fundraising across its private markets platform. Before that, she spent three and a half years at AQR Capital Management on the institutional sales team. Taylor holds a BA in Mathematics from Emory University and an MBA from NYU Stern. She is based in New York.

Shwan Kazzaz is a Principal on B Capital’s Healthcare team. He is focused on strategic minority and control investments in Healthcare IT and Digital Health companies. Shwan also partners with founders and leadership teams to help scale portfolio companies – supporting M&A, operational improvements and GTM optimization from early growth through scale. Prior to B Capital, Shwan held Finance, Operations, and Commercial roles at Collective Health. Before that, he advised payer, provider and pharma clients at Bain & Company on growth strategy, organizational design and performance improvement. Early in his career, he held technology-focused roles across Johnson & Johnson’s Consumer Products and Medical Devices businesses. Shwan earned a B.S. in Bioengineering from the University of California, Berkeley and an MBA from Harvard Business School.

Before joining B Capital, she worked as a data scientist in OCBC’s AI Lab, where she helped integrate generative AI into the bank’s applications. Sherbelle holds a Master of Science in Artificial Intelligence from Nanyang Technological University.

Sarvesh is a Principal in B Capital Group’s Singapore office and focuses on growth investments across South East Asia and India. Previously, Sarvesh was a part of SoftBank Vision Fund’s investment team focusing on South East Asia. Prior to that, he spent 4 years with Temasek’s TMT team looking at investments across US, SEA and India, and covering sub-sectors including marketplaces, enterprise software as well as digital media. Sarvesh started his career doing investment banking with Credit Suisse.

Ryan is an Investor in B Capital’s New York office, where he focuses on FinTech, as well as Blockchain Technology and PropTech. Prior to B Capital, Ryan worked in investment banking at Barclays, where he focused on FinTech M&A and Capital Markets. Ryan is from New York and graduated from Duke University with a BA in Public Policy. In his free time, Ryan enjoys cooking, watching the English Premier League and spending time with family and friends.

Ryan Ee is Manager of AI Operations at B Capital, where he develops products with his team to advance the firm’s AI and data initiatives. He brings hands-on experience from across the startup ecosystem, including roles at Speedoc, a technology-enabled healthcare platform, and other early-stage ventures. Prior to that, he spent four years at Changi General Hospital, contributing to digital health and operational innovation. Ryan has developed mobile apps, games and web platforms, with a strong interest in end-to-end product delivery and scalable system design. He holds a Bachelor of Science from the National University of Singapore. He is based in Singapore.

Ronan Kennedy is a Managing Director of Capital Advisory & Corporate Development.  He advises portfolio company leadership on their most strategic transactions, including M&A execution, capital raising  and public-market readiness.  Ronan is also a contributing member of our firm’s Strategic Growth Equity team. Before joining B Capital, Ronan helped build the private equity team at M12, Microsoft’s Venture Fund, where he partnered with leading growth equity and buyout firms to invest into and help scale, large scale tech companies. He previously served as a Vice President at Goldman Sachs and as an Associate at JPMorgan Chase.  Ronan began his career in the United States Army, where he served two tours leading soldiers on the fronts lines of Iraq.

Reshma brings extensive experience in investment adviser and broker-dealer regulatory matters across some of the world’s most respected financial institutions, with particular focus on the Investment Advisers Act and international regulatory compliance. Most recently, Reshma was a Managing Director and Chief Compliance Officer at 1919 Investment Counsel, where she led the firm’s compliance program and served on its Operating Committee and Stifel’s Compliance Executive Committee. Prior to that, she held senior compliance roles at PIMCO and Barclays, and earlier in her career served in compliance at The Carlyle Group. Beyond her financial services career, Reshma gained experience implementing micro-finance programs in areas affected by civil wars and conflicts, including Rwanda, Bosnia and Herzegovina and Kosovo. She holds a B.A. from American University and serves on the Board of Advisors of Hillwood Estate, Museum & Gardens and the Board of Trustees of Buckley Country Day School.

Reaz Khoshru is a Vice President of Finance at B Capital, where he focuses on finance, operations and portfolio analytics. Before joining B Capital, Reaz was a Fund Accounting Manager at Standish Management, where he provided consulting and fund administration services to private equity firms.

Raven Tan is Vice President of Information Technology at B Capital, where he oversees the firm’s global IT operations, infrastructure and systems strategy. He plays a key role in ensuring secure, scalable and efficient technology solutions to support the firm’s growth and cross-border operations. Raven brings more than a decade of experience leading enterprise IT functions. Prior to joining B Capital, he was Vice President of Private Cloud Services at GIC, where he managed critical infrastructure platforms. Earlier in his career, he spent eight years at Micron Technology as a Wintel IT Manager within the Global Shared Services Center, supporting manufacturing operations worldwide.

Ragini Chawla is a Director of Strategy at B Capital, where she works with firm leadership on strategic initiatives, investments and portfolio value creation. Before joining B Capital, Ragini was a Vice President at Trident, a middle market buyout firm, where she underwrote and managed investments across consumer, healthcare and industrials and led strategic initiatives across multiple funds. Earlier in her career, she worked at the Milken Institute’s Center for Financial Markets, focused on addressing global capital markets challenges through financial innovation. Ragini holds a B.A. in Economics and International Relations from New York University. She is based in Los Angeles.

Priya Banerjee is a Senior Principal at B Capital, where she focuses on technology investments within AI, B2B software and fintech verticals. She brings experience across venture capital, strategic finance and consulting. Prior to joining B Capital, Priya was an investment professional at Sequoia Capital India, where she sourced and evaluated high-growth startups in the consumer and healthcare sectors. She began her career as a management consultant at McKinsey & Company, where she specialized in digital transformation strategies for clients in financial services and healthcare. While earning her MBA at the Wharton School, Priya was also an Investment Partner at Dorm Room Fund, First Round Capital’s student-led investment arm, where she helped lead over 25 investments into early-stage companies founded by students across the U.S. She holds a degree in Computer Engineering from the National University of Singapore and is based in San Francisco.

Pierre Colmenarez is a Finance Manager at B Capital, where he supports financial operations and reporting across the firm. He brings extensive experience in fund administration and financial oversight within the asset management industry. Prior to joining B Capital, Pierre was an Assistant Vice President at U.S. Bank Global Fund Services, where he led fund administration for registered investment companies. He began his career at PricewaterhouseCoopers as a Senior Associate in the financial services and alternative investments practice, auditing private equity funds, investment advisors and large fund complexes. Pierre holds a B.S. in Business Administration with emphases in Accounting and Finance from the University of California, Riverside, and is a Certified Public Accountant. Pierre is also a member of the CFA Institute and a Level III candidate in the CFA program.

Phil Vickers is a Talent Acquisition Manager at B Capital, where he leads recruitment for investors, operations professionals and talent advisory roles across the portfolio. He brings over 15 years of experience building high-performing teams across technology and life sciences, with a strong background in AI and technical recruiting. Before joining B Capital, Phil held senior talent roles at leading companies including Karma Automotive and Masimo, where he focused on sourcing and scaling technical talent across AI and research teams.

Our Team Patrick Harmon Senior Principal Function: Investment Location: Americas - Los Angeles Stage: Early Stage Expertise: Technology / AI LinkedIn Patrick Harmon is a Senior Principal at B Capital, where he focuses on early-stage investments. Before joining B Capital, Patrick worked with BMW iVentures and Morpheus Ventures, participating in deals across frontier tech, enterprise software and fintech. He was previously at Dalus Capital in Mexico City, leading early-stage investments in enterprise software and fintech. Patrick began his career in strategy consulting at Deloitte. Patrick holds an MBA from the University of Chicago Booth School of Business and a bachelor’s degree from Vanderbilt University. He is based in Los Angeles.

Nupoor Wadekar is an Investor Relations Associate at B Capital, where she supports the firm’s capital formation and institutional LP relations efforts across its global platform. Before joining B Capital, Nupoor worked at TPG, where she supported flagship private equity and tech growth equity fundraises. Prior to TPG, she worked in technology investment banking at Bank of America. Nupoor holds a B.S. in Finance and Computer Science from St. John’s University’s Peter J. Tobin College of Business. She is based in New York.

She began her career in M&A with Standard Chartered Bank before moving into private equity with Standard Chartered Private Equity and Affirma Capital, where she focused on growth investments across Southeast Asia. More recently, Novia worked in-house with several high-growth startups, including Novi Health, Doctor Anywhere, and Flash Coffee, supporting them through scaling and fundraising. Novia graduated with First Class Honours in Accounting from Nanyang Technological University in Singapore, where she studied on a full scholarship.

Our Team Nick Giometti Senior Principal Function: Investment Location: Americas - San Francisco Stage: Early Stage, Growth Stage Expertise: Technology / AI LinkedIn Nick Giometti is a Senior Principal at B Capital, where he focuses on partnering with machine learning, data and infrastructure businesses. Before joining B Capital, Nick was a Vice President at Geodesic Capital, where he invested in companies including Figma, Fly.io, Chronosphere, Sourcegraph, TRM Labs, Viz.ai and Edge Delta. He previously worked at BlackRock as a systematic investor, deploying capital at the intersection of data science, fundamental analysis and workflow automation. Nick holds an MBA from the Kellogg School of Management and a B.A. in Economics and English from Dartmouth College. He is based in San Francisco. Related Content 1/1 Article | Insights RAG and the Future of Intelligent Enterprise Applications: Insights from Startup Leaders April 2, 2025 This article was originally published by Microsoft for Startups, access the original here. By: Nick Giometti and Rob Ferguson  … Learn More →

Nate Johnson is a Senior Associate on B Capital’s Energy investment team, where he focuses on growth-stage companies innovating across resilience tech, energy and other critical industries. Prior to B Capital, Nate was a Project Leader at Boston Consulting Group, advising energy and private equity clients on strategy, operations and large-scale transformations. He also brings hands-on climate tech experience as both an investor and operator, having worked with Energy Capital Ventures and startups including Radia and Via Separations. Nate holds a B.S. in Mechanical Engineering from MIT and an MBA from the University of Chicago Booth School of Business.

Narmeen Haider is a Venture Director at B Capital, where she provides strategic support on firm strategy and operations. She began her career in the global health sector, partnering with organizations such as the Gates Foundation and the World Health Organization to address critical challenges in maternal health, vaccine access, and HIV/AIDS. She later worked at BCG, where she advised clients across the technology, healthcare and private equity sectors. Today, she is also co-founder of Lumara Health, a healthcare startup building agentic AI solutions to transform how organizations engage with patients. Narmeen holds a Master’s in International Health Policy from the London School of Economics and an MBA from Harvard Business School. She is based in San Francisco

Mehul Garg is a Senior Associate at B Capital, where he focuses on early and growth-stage investments. Before B Capital, Mehul was a Consultant at Bain & Company, advising clients on commercial due diligence, value creation strategies, and go-to-market initiatives across industries (SaaS, IT services, and consumer). Earlier, he was part of Growthstory, a startup accelerator, where he advised consumer-tech portfolio founders on scaling and growth initiatives. Mehul holds an MBA from the IIM Lucknow and a Bachelor’s degree in Engineering from the IIT Guwahati. He is based in Delhi.

Megan Kotrappa is a Senior Associate on B Capital’s Healthcare team, where she focuses on investments across medical devices and biotechnology. Prior to rejoining B Capital, Megan was an investor at Global Health Investment Corporation. She previously worked at B Capital as a Healthcare Associate and began her career in Healthcare Investment Banking at Goldman Sachs. Megan holds an MBA from Harvard Business School and an MS in Biotechnology from Harvard University. She earned a Bachelor of Science in Engineering and a Bachelor of Science in Economics from the University of Pennsylvania through the Jerome Fisher Program in Management and Technology.

Meg is B Capital’s Managing Director, Head of HR. She oversees strategic HR initiatives and talent acquisition needs across the global organization. With over 20 years of experience, Meagan specializes in aligning HR strategies with business objectives, cultivating high-performance cultures and implementing cutting-edge HR technologies. Her expertise extends to developing leadership pipelines, succession planning and navigating complex organizational transformations. Before joining B Capital in April 2022, Meagan held leadership roles at Masimo, where she led Global Recruiting and at Western Digital, where she served as Director of Global Talent Acquisition. Her international experience includes heading Asia-Pacific Recruitment, Training and Events at Oliver Wyman in Singapore, providing her with a valuable cross-cultural talent management perspective.

Louie is the Senior HR Operations Manager supporting B Capital’s internal staff focusing primarily on payroll, 401k and benefits and HR. Louie is joining the company after a 3-year stint at TikTok where he spearheaded payroll initiatives and led the US payroll team in filling in gaps during the start of the WFH mandate in 2020. Prior to TikTok, he worked alongside different industries across US providing HR, payroll and benefits solutions where he gained a multitude of experience that made him a subject matter expert in the HR world. Louie has earned his BA in Psychology from CSUN and holds an HR Management certification from Loyola Marymount University.

Our Team KweeBee Teo Vice President Human Resources Function: Specialists Location: Southeast Asia - Singapore LinkedIn Twitter KweeBee Teo is Vice President of Human Resources at B Capital, where she leads strategic people initiatives across Asia to drive growth, optimize employee experience and enhance workforce engagement. With over 25 years of experience spanning the energy, education and banking industries, KweeBee has led regional initiatives in talent development, culture and workforce transformation, diversity and inclusion and employer branding. Before joining B Capital, she was Executive Director of Human Capital, Employee Communications & Engagement at the Bank of Singapore. She previously held leadership roles at Credit Suisse, Royal Bank of Scotland and Caltex Singapore. KweeBee holds a Master of Science in Marketing from University College Dublin and a Bachelor of Arts in Psychology from NUS. She is based in Singapore.

Kelly Qiao is a Senior Principal at B Capital, where she leads healthcare investments across Asia. She focuses on opportunities in biotech, medtech and digital health. Since joining B Capital, Kelly has invested in and serves on the boards of Insilico Medicine, ProfoundBio (acquired by Genmab), Grit Biotechnology, Rona Therapeutics, Vivacta Bio, Spectrumedics Medical, Macrolux Medical, and AlphaLife Sciences. She has also invested in MediTrust Health and Yuanxin Technology. Prior to joining B Capital, Kelly built over a decade of experience across healthcare investing and operations. She previously worked as Managing Director for global healthcare investment at Fosun ( 656.HK ). Prior to that, Kelly served as an Executive Director at Vertex Ventures, where she invested in Chipscreen Biosciences (688321.SH) and Phoenix Healthcare Group ( 1515.HK ), and served on the Board of Chipscreen. She also worked in drug discovery at GlaxoSmithKline and sales and marketing at Roche. Kelly holds a PhD in Biology and a BSc in Chemistry from Tsinghua University and an MBA in Finance from The Chinese University of Hong Kong.

Keegan McGuire is an Associate on the Healthcare investment team at B Capital, where he focuses on early-stage opportunities in health tech and medical devices. Before joining B Capital, Keegan was at Arboretum Ventures, where he supported early-stage investments in medtech companies. He began his career in Deloitte’s life sciences and healthcare practice, advising clients on strategic and operational initiatives across the healthcare ecosystem.

Kate is a strategic investor relations and communications leader with a demonstrated track record of driving results across public companies, private firms, and venture capital portfolios. Most recently, Kate served as Head of Investor Relations and Communications at Vida Ventures, where she led the firm’s investor relations, fundraising, flagship events, and communications strategies, while also advising portfolio companies on their IR and corporate communications programs. Before joining Vida in 2020, Kate built and executed investor relations and integrated communications strategies around groundbreaking therapies, including YESCARTA® (the first approved CAR-T therapy for relapsed or refractory non-Hodgkin lymphoma) and Jelmyto™ (the first and only non-surgical treatment for adults with low-grade upper tract urothelial cancer). She previously served as Head of Investor Relations at UroGen Pharma and was a key member of Kite Pharma’s Investor Relations and Communications team until its acquisition by Gilead Sciences in 2017. Earlier in her career, Kate held roles of increasing responsibility at Memorial Sloan Kettering Cancer Center in New York. Kate holds a B.A. from Cornell University College of Arts & Sciences and an M.B.A. from the University of Southern California’s Marshall School of Business.

Kanika Puri is an Executive Assistant at B Capital, where she supports senior leaders in the India and Singapore offices. She brings deep experience in high-level executive support, having previously worked at BCG and GE Capital. Throughout her career, Kanika has partnered closely with Managing Directors and senior leadership, managing complex calendars, coordinating cross-functional priorities and ensuring operational efficiency in fast-paced environments. She is known for her strong organizational skills and ability to anticipate and adapt to changing demands.

He began his career in aerospace engineering before transitioning into software and data engineering. Prior to joining B Capital, he held roles at SP Digital, TikTok, and Prudential, where he developed data services, backend systems, and tools to improve scalability and efficiency across business lines. Kai holds a Bachelor of Aerospace Engineering and a Master of Engineering (Honors) from the University of Cambridge.

John Chua is a Managing Director of Capital Advisory at B Capital, where he partners with portfolio company leadership across Asia to address their capital needs. Before joining B Capital, John was a Managing Director at Jeneration Group, specializing in SPACs and growth-oriented technology investments across Greater China. From 2017 to 2020, he co-led Grab’s Corporate Finance team, raising over $6 billion in equity capital from investors including Toyota, Invesco/Oppenheimer, Ping An, Microsoft, Booking Holdings and MUFG. Earlier in his career, he spent 14 years in investment banking at Nomura and Lehman Brothers in Hong Kong and New York.

Joe Oleynik is an Associate at B Capital, where he focuses on investments in enterprise software and emerging technologies. Before joining B Capital, Joe was an investor at DCVC, a deep tech venture firm, where he evaluated opportunities across AI, data infrastructure and applied science. He began his career as an investment banking analyst at Union Square Advisors, advising software companies on M&A transactions.

Joanna Huang serves as a Senior Manager on the Talent Acquisition team at B Capital, where she oversees recruitment and HR business partnering across the Asia Pacific region. She plays a key role in sourcing top-tier talent and managing the full-cycle hiring process for investment teams, internal operations, and portfolio companies throughout APAC. Prior to joining B Capital,  Joanna worked as a Senior Consultant at Morgan McKinley in both London and Singapore, specializing in talent acquisition for sectors including private equity, venture capital, consulting, investment banking, and other buyside firms. She earned her Bachelor of Science with Honors in Management from Royal Holloway, University of London.

Joanna Aarvold is an Executive Assistant at B Capital with over two decades of experience in commercial and operational roles, primarily in the finance sector in Singapore. She began her career in pharmaceuticals at AstraZeneca before transitioning into finance, where she supported trading desks and senior leadership at UBS and hedge funds, including Lionhart and Millennium. Over the last 14 years, Joanna has focused on operations and compliance, supporting C-suite executives at Ninety-One and Arbor Ventures. She holds a B.Sc. with Honors in Pharmacology from the University of Edinburgh.

Our Team Jenny Xie Deputy General Counsel Function: Specialists Location: Southeast Asia - Singapore LinkedIn Jenny Xie is Deputy General Counsel at B Capital, leading the APAC legal function and supporting investments across the region. Before joining B Capital, Jenny was the legal lead for deals and exits in APAC at SoftBank Vision Fund. She previously worked in the corporate and private equity team at Gibson & Dunn and the securities and public companies team at Ropes & Gray. She began her career at Milbank Tweed, advising on capital markets and venture capital transactions across Asia. Jenny holds a Juris Doctorate from Columbia Law School and a B.A. in International Relations and Economics from Hampshire College. She is based in Singapore.

Jeffrey Goldsmith is a Senior Associate at B Capital, based in Los Angeles. He focuses on supporting early and growth-stage investments across the firm’s technology portfolio. Prior to joining B Capital, Jeffrey was a strategy consultant at Dean & Company, where he advised clients in the energy, telecom infrastructure and technology sectors.

Prior to joining B Capital, Jason worked at Brightstar Capital, focusing on investments in closely held middle-market companies. He began his career in Citigroup’s healthcare investment banking group. Jason holds an MBA from the University of Chicago Booth School of Business and an AB in Economics from Princeton University.

Jason joins us as the VP, Finance in B Capital’s Singapore office, where he focuses on the finance, tax structuring and operations of B Capital Group’s investments in Asia Pacific. Jason has experience in fund accounting, operations and audit for private equity, hedge funds and fund managers in the last 16 years. Prior to joining, Jason was a Director of Finance and Operations with Kerogen Capital in HK, heading the finance and operation of Kerogen Group. Jason previously worked for Avenue Capital (Special Situations), CLSA Capital Partners (Mezzanine and Clean Resources) and PricewaterhouseCoopers in Singapore. Jason holds a Bachelor of Accountancy Degree from the Nanyang Technological University in Singapore. He is a Chartered Accountant under both ICAEW in UK and ISCA in Singapore. In his free time, Jason loves golfing and playing badminton.

Jana Ishak is the Office & Special Events Manager at B Capital. She oversees daily office operations in Singapore and plays a key role in coordinating firmwide events across the region. With more than 20 years of experience in executive and operational support, Jana brings deep expertise in managing high-level administrative functions and logistical execution. Prior to joining B Capital, she spent nearly a decade at TPG Capital, supporting senior members of the Deal and Operations teams. She began her career at Kellogg, Brown & Root in Singapore, where she supported regional leadership.

Jade Ma is a AI Manager at B Capital, focusing on leveraging GenAI technologies to enhance the firm’s digital capabilities. Jade brings several years of experience in software development, with expertise in both front-end and back-end frameworks within the financial sector. She holds a Bachelor of Engineering Science specializing in Computer Science and a Master of Science in Technology Management from Nanyang Technological University.

Prior to joining B Capital, Ishan worked at Lead Edge Capital, where he focused on sourcing and evaluating software and tech-enabled services businesses. Ishan holds a Bachelor of Business Administration and a Bachelor of Arts in Economics from the Haas School of Business at the University of California, Berkeley. He is based in New York.

Braingels member with philanthropic and trauma-relief experience. His published biography describes education, caregiver support, mindfulness programmes and funding interests in neurodegeneration, brain-computer interfaces and related research.

Braingels member, AI researcher, product designer and entrepreneur. His published biography describes Siri design, former Apple advanced development leadership and advisory work on technologies intended to improve human wellbeing.

Braingels co-founder, entrepreneur and private investor. His published background spans internet, cybersecurity, mobility, financial technology and AI, with interests in neurotechnology and brain health.

Braingels co-founder with AI research and technology leadership experience. His published biography describes Inflection AI, prior Mozilla research leadership and work across computing, neuroscience and social impact.

Braingels member with computational neuroscience, psychiatry and biotechnology entrepreneurship experience. His published biography describes neural augmentation research, brain organoid drug discovery and co-founding Herophilus.

Braingels member, artist and investor whose work spans technology, perception and visual art. Her published investment interests include human enhancement, AI, robotics, biotechnology and cryptographic infrastructure.

Braingels member with clinical psychology and mental health service development experience. Her published biography describes Wave Life, evidence-based care and prior clinical, product and engineering leadership at Octave.

Braingels member, also known as Sam Alkan, with advisory experience in emerging ventures, family businesses and impact philanthropy. Her published interests include rare pediatric disease care and youth mental wellness.

Braingels member with entrepreneurship, data science and angel investing experience. His published biography describes Shopping.com, Thready, former Facebook advertising leadership and work exploring neurotechnology data.

Braingels member with entrepreneurship and venture investing experience spanning internet technology, finance, gaming and biotechnology. The community does not publish a separate executive office for him.

Leads Braingels operations, including deal flow, founder relations and expert programming. Her published biography describes work on AI products, safety and wellbeing, and Stanford training in neuroscience and management science.

Braingels member with early-stage investment interests in digital health, functional medicine and the microbiome. His published biography describes involvement in the Quantified Self movement and technology ethics.

Braingels member and private investor focused on brain fitness, medical innovation and behavioral health. His published biography describes prior asset management experience and work supporting neuroscience organizations.

Braingels member with early-stage investing, national security and organizational leadership experience. His published biography describes research on leadership and the behavioral science of organizational performance.

Braingels member, physician-scientist and angel investor. Her research and clinical background include pediatric intensive care, neonatal brain injury and preclinical neurotherapeutic development.

Braingels member with life sciences investment, venture development and business strategy experience. His published biography describes prior mental health therapeutics and neurotechnology work at atai Life Sciences.

Braingels member and BrainMind co-founder, with experience connecting neuroscience researchers, entrepreneurs and philanthropists. Her published biography also describes biotechnology research and STEM entrepreneurship programmes.

Braingels member with medical device development and product strategy experience. His published biography describes work on biophysics-based health technology, digital diagnostics and therapeutics.

Braingels member whose work combines psychiatry, neuroscience and biomedical engineering. His published biography describes EEG-guided brain stimulation research and co-founding Alto Neuroscience.

Braingels member with digital health entrepreneurship and early-stage investing experience. Co-founded patient community PatientsLikeMe and has worked on digital biology, privacy and deep technology ventures.

Braingels member with entrepreneurship and deep technology investing experience, and training in theoretical physics and business administration. His published biography focuses on translating technical advances into viable businesses.

Ida Girma is a Principal at B Capital, where she focuses on early- and growth-stage investments in technology and AI companies that are positively shaping the future. Prior to joining the firm, Ida was a private equity investor at TCG and previously worked in consulting at Bain & Company, investment banking at JP Morgan and as an operator at clean energy finance startup Nithio. Earlier in her career, she helped establish the impact investing practice at Arabella Advisors and worked with the United Nations World Food Programme in Ethiopia. Ida earned an MBA from the Stanford Graduate School of Business, an MPA from the Harvard Kennedy School and a BA magna cum laude from Columbia University. She is based in San Francisco.

Hugh Lu is a Principal at B Capital, where he focuses on sourcing and executing growth and early-stage investments in China. Prior to joining B Capital, Hugh was a consultant at Boston Consulting Group, where he advised clients in private equity, technology, media and financial services. His work spanned multiple markets, including China, Japan and India, with a focus on due diligence and growth strategy.

Gordon Woon is a Senior Full Stack Developer at B Capital, where he designs and builds internal tools and platforms to support global operations.

Emily Gu is an Executive Assistant at B Capital, where she supports senior leadership in the San Francisco office. She brings prior experience from both nonprofit and commercial real estate sectors, where she managed complex scheduling, coordinated team logistics and supported day-to-day operations.

Our Team Elice Ongko Senior Associate Function: Investment Location: Southeast Asia - Indonesia Stage: Early Stage, Growth Stage LinkedIn Elice Ongko is a Senior Associate at B Capital, focusing on early and growth-stage investments in Indonesia. Before joining B Capital, she built a diverse career across finance, consulting, and operations. She worked in M&A at KPMG, strategy consulting at McKinsey, and investing at Northstar, gaining deep expertise in deal-making and business transformation. She also honed her operational skills at Hypefast, a fast-growing startup in Indonesia. She is based in Jakarta. Related Content 1/1 Article | Why We Invested Why We Invested: Eureka Robotics January 9, 2025 By: Karan Mohla, Sarvesh Agarwal, and Elice Ongko B Capital is pleased to partner with Singapore-based Eureka Robotics, an automation… Learn More →

Deepanshu Pattanayak is a Principal at B Capital, focusing on investments in South and Southeast Asia. Prior to joining B Capital, Deepanshu was a Principal at Pravega Ventures, where he focused on pre-seed and seed-stage investments across SaaS, fintech, consumer tech and B2B marketplaces. Before Pravega, he worked at Bain & Company, specializing in private equity, due diligence and consumer tech. Deepanshu holds a Bachelor’s degree in Engineering from IIT Kharagpur and an MBA from IIM Bangalore. He is based in Bangalore.

Deepa Balji is a Vice President, Marketing & Communications at B Capital, where she leads the firm’s marketing and communications efforts in Asia. With a background in financial journalism, Deepa focuses on driving data-driven storytelling to highlight opportunities in the startup and venture capital ecosystem across Asia and the Middle East. Prior to joining B Capital, Deepa was a Director at S4 Capital, a global digital media and marketing agency. She brings over 15 years of experience in PR and communications and is passionate about upskilling and elevating women.

David Helton is an Executive Assistant and Office Manager at B Capital. With over 16 years of experience in early-stage startups and a decade of collaborating with top-tier venture capital firms, David brings a wealth of expertise in executive support and operations. David’s career began in hospitality at the Naniloa Resort in Hawaii and the Fairmont Hotel in San Francisco, managing high-profile events. He later contributed to startups like Napster and Trifacta (acquired by Alteryx), with additional roles at BrightRoll (acquired by Yahoo!) and Wantful (acquired by Nordstrom).

Our Team Daryl Tan Data Engineer Function: Specialists Location: Southeast Asia - Singapore LinkedIn Daryl Tan is a Data Engineer at B Capital, where he builds and manages data infrastructure to support decision-making across the firm. Before joining B Capital, Daryl worked in the AI & Data Centre of Excellence at Temus, building analytics infrastructure for clients in the insurance and manufacturing sectors. Earlier in his career, he was part of the Marketing Analytics team at Shopee, where he provided data-driven insights for campaigns and promotions across Southeast Asia and Latin America. Daryl holds a Bachelor of Business specializing in Business Analytics from Nanyang Technological University. He is based in Singapore.

Our Team Cindy Park Deputy Chief of Staff Function: Specialists Location: Americas - Los Angeles LinkedIn Cindy Park is Deputy Chief of Staff to the Co-Founder and Co-CEO at B Capital, supporting strategic initiatives and operations. She joined B Capital as Executive Assistant to the Co-Founder and Co-CEO before transitioning to Operations Manager, working closely with the firm’s COO. Before B Capital, Cindy worked in retail product development at Bloomingdale’s/Macy’s Merchandising Group, Barney’s New York, and Lacoste. She later served as Chief of Staff to the founder of a branding startup supporting early-stage entrepreneurs in the creative industry. Cindy holds a B.B.A. in Management and Design from Parsons School of Design. She is based in Los Angeles.

Our Team Christina Gilchrist Senior EA Coordinator Function: Specialists Location: Americas - Los Angeles LinkedIn Christina Gilchrist is a Senior EA Coordinator at B Capital. Before joining B Capital, she worked at Renaissance Technologies, Barclays Global Investors (now BlackRock) and Marathon Asset Management. Christina studied Math and Asian American Studies at UCSB. She is based in Los Angeles.

Our Team Chris Lim Vice President, Investor Relations Function: Specialists Location: Southeast Asia - Singapore LinkedIn Chris Lim is a Vice President on the Investor Relations team at B Capital, where he supports fundraising and investor engagement efforts. Before joining B Capital, Chris worked at Cambridge Associates as an Investment Performance Analyst, specializing in performance measurement and client reporting. Chris holds a degree in Economics with specializations in Financial Economics and Applied & Policy Economics from the National University of Singapore. He is based in Singapore.

Chris Casillas is a Finance Manager at B Capital, where he supports financial operations and reporting across the firm. Prior to joining B Capital, Chris held finance roles at Toyota Ventures, Carta, and Foundation Capital. Earlier in his career, he worked in public accounting across audit, tax, and consulting.

Our Team Brian Alter Principal Function: Investment Location: Americas - New York Stage: Growth Stage LinkedIn Brian Alter is a Principal at B Capital, where he focuses on strategic growth investments. Before joining B Capital, Brian was a venture fellow with Pear VC and evaluated investments as an intern with the U.S. government’s equity investments office. He previously led the Finance and Strategy function at Artsy and began his career in investment banking at Jefferies. Brian holds an MBA from the Wharton School at the University of Pennsylvania and a B.S. in Human and Organizational Development from Vanderbilt University. He is based in New York. Related Content 1/1 Article | Why We Invested Why We Invested in Lambda February 15, 2024 By Suman Natarajan, Brian Alter, Jeff Goldsmith Background / The Problem The advances in deep learning mark one of the… Learn More →

Before joining B Capital, Brendon was an Associate in the Asset Management Department at Ropes & Gray, a global law firm. His practice focused on advising asset managers and private funds on formation, regulatory, transactional and compliance matters. Brendon also counseled clients on cryptocurrency investments, cryptocurrency fund formation, trading, custody, valuation issues and the related regulatory and enforcement landscape, including compliance with SEC and CFTC regulations. Brendon holds a Juris Doctorate from Fordham University and a B.A. from Loyola University Maryland. He is based in New York.

Our Team Ben Phelan Deputy Chief Financial Officer Function: Specialists Location: Americas - Los Angeles LinkedIn Ben Phelan is Deputy Chief Financial Officer at B Capital, where he oversees finance, operations, accounting, and portfolio management. Before joining B Capital, Ben worked at Leonard Green & Partners, a private equity firm in Santa Monica. He began his career in the Financial Services Assurance Group at PricewaterhouseCoopers (PwC) and is a Certified Public Accountant. Ben holds a B.A. in Accounting from the University of Iowa and a Master of Professional Accountancy from the University of California, Irvine. He is based in Los Angeles.

Audrey Mandaro is the Capital Formation Manager at B Capital, where she supports the Investor Relations team on fundraising and capital formation initiatives across the firm’s global platform. Before joining B Capital, Audrey worked in wealth management at Morgan Stanley and AllianceBernstein, partnering with financial advisors to support high-net-worth clients and manage complex investment portfolios. Audrey holds a B.A. in Political Science from the College of the Holy Cross and a certificate in Business Fundamentals. She is based in Los Angeles.

Alex Accardi is the administrativeassistant listed inOptumVentures currentdirectory, whose biography identifiesreceptionistduties. She has overtenyears ofelementarychildcareexperience and supports thefirm’s officevisitoroperations. No investmentexecutivecapacity is inferred fromadministrativeaffiliation.

Millie Walton-Smith is Optum Ventures global executiveassistant andofficemanager inLondon, supportingVijayBarathan andtheglobaloffice. Previously she worked inhealthcareexecutiveassistance inNewZealand. Her studies atAuckland/Otago includedpsychology.

Our Team Athena Shea Senior Associate, Healthcare Function: Investment Location: Americas - San Francisco Stage: Early Stage, Growth Stage Expertise: Healthcare LinkedIn Athena Shea is a Senior Associate at B Capital, focusing on investments in digital health and healthcare IT. Before joining B Capital, she was an investor at Partners Capital, where she managed multi-asset class portfolios and helped grow the firm’s West Coast office. She previously worked at Accenture Strategy’s Health and Public Services group, advising on operating model, growth and cost optimization strategies. Athena holds a B.S. in Policy Analysis and Management from Cornell University. She is based in San Francisco.

Elizabeth Luke is an Optum Ventures executiveassistant supportingLauraVeroneau andStephenRenfro. Her background includesCitadel executiveassistance and administrative/eventsroles atStarbucks andFidelity. She studiedcommunications/arthistory atJohnCabotUniversity; ownportrait is presently a genericfirmmarkplaceholder.

Our Team Ashley O’Connor Senior Marketing Manager Function: Specialists Location: Americas - New York LinkedIn Ashley O’Connor is a Senior Marketing Manager at B Capital, where she drives marketing strategies that enhance the firm’s brand awareness and thought leadership. Ashley brings over a decade of communications and marketing experience. Prior to joining B Capital, she held roles at Ansa Capital, Work & Co, Dan Klores Communications and SS+K, where she developed and executed impactful marketing campaigns. Ashley serves on the jury of the Webby Awards, which recognize excellence on the internet. She earned a B.A. in Political Science from Williams College. She is based in New York.

Taylor Trepagnier supports Optum Ventures investmentstaff and firmmarketing/events. Her directoryheading isInvestmentTeamAssistant; the biography describesAdministrativeAssistant, a qualifiedheadingdifference. She previouslysupportedhumanresources/recruiting/training atBainCapitalPE and studiedmarketing atSuffolkUniversity.

Before joining B Capital, Annie held long-term roles at Deutsche Bank, Barclays and Forge Global, where she supported executive teams through IPO preparation, international expansion and major corporate transitions. Throughout her career, she has been known for navigating complexity, driving efficiency and building strong partnerships across organizations. Annie holds a B.S. in Business Management from Rutgers University.

Megan Hurley coordinates marketing atOptumVentures. Her priorfinance-industrymarketing experience includesMFSInvestmentManagement andBaystateFinancials. She studiedmarketing atFairfieldUniversity.

Our Team Akash Khandelwal Senior Associate Function: Investment Location: India Expertise: Technology / AI LinkedIn Akash Khandelwal is a Senior Associate at B Capital, focusing on early-stage investments. Having been a founder himself, Akash combines his entrepreneurial experience with investing expertise to support founders in their journey. Before joining B Capital, Akash was part of the investment team at Tanglin Ventures, where he specialized in SaaS, fintech, consumer tech and B2B marketplaces. Akash holds a Bachelor’s and a Master’s degree in Engineering from IIT Kharagpur. He is based in Bangalore.

Julie Joyce supports LarryRenfro as Optum Ventures senior executiveassistant, the exact currentdirectoryheading. She previouslysupportedJackConnors inBoston for27years. The ownbiography uses ExecutiveAssistant ratherthan a different executiveleadershiprank.

Adrian Alvarez is a Senior Manager, Finance at B Capital, supporting financial operations across the firm. Before joining B Capital, Adrian spent six years in public accounting at EY Los Angeles and BDO Los Angeles/Bay Area, specializing in asset management companies.

Bailey Summerfield is an Optum Ventures portfoliofinanceassociate. Her earlierDeloitte transactionadvisory focused onlife-sciencesM&A,followingalternativeinvestment valuationwork atAlvarez&Marsal. She studiedfinancialeconomics atBinghamtonUniversity.

Abhiram (Abe) Kumar is a Principal at B Capital, where he focuses on early-stage investments. Abe combines his investing expertise with a strong background in startup operations, bringing valuable insights and support to ambitious  aiming to build transformative companies. Before joining B Capital, Abe played a key role as the second business hire at Gather, a virtual office software company, where he led growth and go-to-market functions during a period of rapid expansion. Previously, Abe was investor at CapitalG, Alphabet’s $7 billion+ growth investment arm, where he focused on early-and growth-stage companies in the software, cybersecurity, fintech and healthcare sectors. Abe also contributed to launching CapitalG’s office in India. Before CapitalG, he was at Evercore, advising clients on mergers and acquisitions. Abe holds a BS in Finance and Actuarial Science from New York University and an MBA from Stanford Graduate School of Business. He is based in New York.

Liz Dietz manages accounting andtax atOptumVentures. Previously she worked onPwC asset/wealthmanagement tax,includingpartnershipcompliance forrealestateclients. She studiedaccounting atBentley andis aMassachusettsCPA.

Youcef Oudjidane is a Venture Partner at B Capital, where he supports the firm’s investing activities across the Middle East. Youcef is the Founder and Managing Partner of BYLD, an institutional venture capital firm focused on leading early-stage investments in startups across the region. Prior to BYLD, he co-founded Elevate Pay, a Y Combinator W22 fintech company providing non-U.S. residents with access to FDIC-insured U.S. bank accounts. He began his career in New York helping companies go public before transitioning into venture capital, initially working with the Dubai Government. Youcef holds an undergraduate degree in Mathematics from the University of Nottingham and an MBA from Lynn University. He is based in Dubai and Doha.

Brian Lafond manages portfoliofinance atOptumVentures. Beforejoining he valuedprivate/publicsecurities atValuationResearchCorporation with ahealthcarefocus. He holdsMuhlenberg finance/economics degrees.

Yan-David Erlich (“Yanda”) is a General Partner at B Capital focused on investments in early-stage venture and growth-stage technology companies. A seasoned investor, Yanda is also a former operator and four-time venture-backed founder and CEO. Before joining B Capital, Yanda was the Chief Operating Officer and Chief Revenue Officer at Weights & Biases, an AI developer platform. There he built out and oversaw the sales, customer success, BD & partnerships, strategy and data science teams. Yanda was an angel investor in the company and served as a Director. He also led the company’s Series A representing Coatue Management, where he worked prior to Weights & Biases as a General Partner responsible for helping launch and manage the enterprise practice for the firm’s venture funds. Yanda holds a BS in Computer Science and Electrical & Computer Engineering from Rice University and an MBA from Stanford Graduate School of Business. He is based in San Francisco.

Siyka Kostevska is Optum Ventures financevice-president. Her priorStandishManagement work includedaccounting,tax andfundadministration forVC/PE funds,followingDeloitte financialservicesaccounting. She is aMassachusettsCPA withNortheasternMSA/MBA qualifications.

Virginia Schmitt is a Venture Partner at B Capital focused on Investor Relations Operations. Virginia has been with the firm since 2017 and was previously in the CFO role before transitioning to the Investor Relations team is 2022. Prior to joining B Capital, Virginia was a Vice President on the investment and operations teams at OpenGate Capital, a global lower-middle market focused private equity firm. She is a Certified Public Accountant (inactive) and began her career in the Transaction Advisory Services group at Ernst & Young. Virginia spent her undergraduate years at the University of Southern California and earned a BS in Accounting from the Leventhal School of Accounting and BS in Business Administration from the Marshall School of Business. She is based in Los Angeles.

Morgan Noonan is an Optum Ventures investmentassociate. Her priorOliverWyman consulting coveredhealthcarestrategy,technologyimplementation andbusinesschange. She studiedbiology andneuroscience atWilliamsCollege; the officialdirectory provides a firmmarkplaceholder rather than an authenticportrait.

Timur Akazhanov is a General Partner at B Capital and is focused on strategic minority and control investments in technology and tech-enabled services companies. He has more than 14 years of private equity experience covering a broad range of industries, including all aspects of deal sourcing, due diligence, deal execution, board governance and capital markets activities. Prior to joining B Capital, he was a Managing Director at H.I.G. Capital focusing on technology and tech-enabled Services. Prior to that he served as a Managing Director in Blackstone’s Corporate Private Equity, a Vice President at Bain Capital and a Business Analyst at McKinsey & Company. Timur holds a BA in Economics from Harvard University and an MBA from Harvard Business School. He is based in New York.

Anna Reilly is an Optum Ventures investmentassociate. She previouslyinvested atImpactEngine,served withTeachforAmerica and worked inMoelis investmentbanking. She holds aDuke publicpolicydegree with globalhealth studies.

Ted Hill is a General Partner and the Chief Financial Officer at B Capital leading the firm’s Finance and Portfolio Analytics teams. Prior to B Capital, he was CFO for Santander Bank’s US Consumer & Business Bank. Previously, Ted held several roles in Digital Strategy, Corporate Development and Finance for JPMorgan Chase, Nationwide Insurance and Bain & Company. He began his career as an Investment Banker in New York and London. Ted graduated magna cum laude with a BA in Economics and Spanish from Bucknell University and an MBA from Harvard Business School. Ted has experience working across Argentina, Spain and England. He is based in Los Angeles.

Courtney Good is an Optum Ventures seniorassociate. Previously atHealthScapeAdvisors she supportedhealthplans/providers withstrategy,operationalchange andvalue-basedcare. She studiedscience-business atUniversityofNotreDame.

Dr. Robert Mittendorff is a General Partner and Global Head of Healthcare at B Capital, where he leads venture and growth investments in category defining healthcare companies. At B Capital, he has invested in and serves on the board of companies such as CapitalRx, Carlsmed, Nalu Medical, Lively, Triumvira, Atomwise and Carrick, among others. Previously, he spent nearly a decade at Norwest Venture Partners as Partner and Co-Head of Healthcare. He has been involved in investments and associated exits with public equity value or acquisition value exceeding $10B. He is a board-certified emergency physician and former public company operating executive with experience spanning investing, complex business development transactions, the leadership of clinical advisory boards, product development, clinical trials, commercial activities and clinical services management. He is a Fellow of the American Academy of Emergency Medicine (FAAEM). He has extensive board experience as both a director and observer at companies including Impel Neuropharma, Avalyn Pharma, Qventus, VisitPay, TigerConnect, Neocis, Talkspace, Omada, Route92, Silk Road Medical (SILK), iCardiac (acq. by eResearch), Telcare (acq. by BioTelemetry, Intersect ENT (Nasdaq: XENT) and iRhythm Technologies (Nasdaq: IRTC). Robert was involved with the initial investments in Misfit Wearables (acquired by Fossil) and Health Catalyst (HCAT), and led seed investments in Myome, Excision Biosciences and Clerio. Dr. Mittendorff was co-chair of the Digital Healthcare Innovation Summit and a member of the Leadership Fellows at Johns Hopkins. Prior to his career in venture capital, Dr. Mittendorff was an executive at Hansen Medical Inc., where he launched the Magellan & Sensei X robots and led the Company’s partnerships with GE, Siemens, Philips and St. Jude Medical. He has worked in portfolio strategy at Merck, as a management consultant at BCG and as an emergency physician at Kaiser Permanente. He earned an MD from Harvard Medical School, trained in Emergency Medicine at Stanford University and earned an MBA from Harvard Business School and a BS in biomedical engineering from Johns Hopkins University. He has completed fellowships with Howard Hughes, MIT and HBS. He is based in San Francisco.

Eliza McGinn is Optum Ventures vice-president. Priorroles includeventure/privateequity investing at.406Ventures andAEAInvestors,managementconsulting atBain and anMBA internship atHumanaCenterWell. She holdsHarvardMBA andYalebachelor’s degrees.

Karly Wentz is a Partner on B Capital’s Energy team focused on investing in growth stage energy and resilience technologies. Before joining B Capital, she was a Vice President at Stonepeak Partners, where she primarily focused on investments in energy infrastructure. Prior to Stonepeak, Karly was an investment banker for Morgan Stanley, focusing on M&A and capital raising in the transportation and logistics sectors. Earlier in her career, she worked in Business Development & Strategy for Ike Robotics, an autonomous trucking start-up. Karly holds a BA in Physics from Middlebury College and an MBA from Stanford Graduate School of Business. She is based in San Francisco.

Mazen Hammad is an Optum Ventures principal, previously a seniorM&A analyst atUnitedHealthGroup. His background includes enterprise transactionexecution andstrategy. He studiedfinance atUniversityofMinnesota Carlson; his studentmanagedfund activity is not anothercorporatecashvehicle.

Austin Martin is an Optum Ventures principal. Beforejoining he consulted onhealthcarepayer/provider networks,Medicaid anddigitalhealth marketstrategies and worked withmultispecialtymedicalgroups. He graduated in economics fromUniversityofTexasatAustin.

Karan Mohla is a General Partner at B Capital where he leads the South and Southeast Asia team. Karan has over two decades experience across finance and technology investing. At B Capital, he has invested across venture and growth investments, including Bhanzu, Sugar.fit, MoEngage, Turno, Nektar, Carro, Eureka Robotics among others. Before joining B Capital, Karan was a Partner at Chiratae Ventures (formerly IDG Ventures India), where he invested in more than 20 companies in the ecommerce, SaaS, logistics, ed-tech, and gaming sectors, including companies such as FirstCry, Xpressbees, and HealthifyMe. Prior to Chiratae Ventures, Karan worked with QVT Finance LP, a U.S. based hedge fund, and in the technology banking group at Jefferies & Company in Silicon Valley, where he was subsequently a founding member of the India office. Karan was recognized as one of the 40 under 40 leaders by Business World Magazine and one of the 40 under 40 Alternate Investment Professionals by the Indian Association of Alternative Investment Funds (IAAIF) . Karan earned a BBA from the Ross School of Business at the University of Michigan and an MBA from INSEAD. He is based between Singapore and India.

Tom Capon is a London-based Optum Ventures global principal. His priorwork includes deeptech engineering/cleantech investing atOxfordScienceEnterprises,healthtechnology investment atLegal&General and EY transactions. He is a charteredaccountant with anImperialCollege economics/strategy MSc.

Nicole Chen is an Optum Ventures principal and LauraVeroneau’s chiefofstaff. Previously she advised employerhealth/benefitplans atWillisTowersWatson and worked withOptum andBostonChildren’s innovationaccelerator. She holds Brown appliedmathematics/economics andDukeFuquaMBA degrees.

Gabe is a General Partner at B Capital focused on early-stage technology investments. At B Capital, he has invested in and serves on the board of companies such as Gameplanner.ai (acquired by Airbnb), Orolabs.ai, Graymatter Robotics, Precision Neuro, BuildOps, Wildfire and When Insurance, among others. Prior to joining B Capital, Gabe was a Partner with Pritzker Group Venture Capital, where he ran the firm’s west coast office. He has sat on numerous company boards and co-founded two companies, which were both acquired. Gabe has been named to LA’s NextGen10 , Chicago Crain’s Tech50 and TechWeek’s Tech100 , and is a Foundation Board Trustee for the Children’s Hospital of Los Angeles (CHLA). He has earned a BA with honors from Washington University in St. Louis, an MBA from Northwestern University’s Kellogg School of Management and a JD from Northwestern University School of Law. He is based in Los Angeles.

Juliet Domb is Optum Ventures executiveinresidence supporting strategicpartnerships withUnitedHealthGroup. Her prior decade atUHG included OptumInsight governmentbusiness,OptumUK chiefadministrativeofficer and OptumCEO chiefofstaff work. She holds aWilliamsCollege classicsdegree. Her currentown image is a firmmarkplaceholder, not an authenticportrait.

Elizabeth has more than three decades of financial services experience, ranging across a variety of leadership roles and alternative asset classes. Before joining B Capital, she served as the Chief Operating Officer and Head of Investor Relations at Cornell Capital, a mid-market private equity firm. Prior to that, Elizabeth was Head of Investor Relations and Head of Human Resources at Viking Global Investors, a global asset manager focused on public and private equity investing. Elizabeth spent nearly 15 years at Goldman Sachs, first as an investment banker and then in the Merchant Banking Division, where she served as Chief Operating Officer of the credit investing platform and then deputy Chief Operating Officer of the division. She earned a BA from the University of Pennsylvania and an MBA from The Wharton School. She is based in New York.

Jon Sklaroff is an Optum Ventures investmentpartner who rejoined afterworking atRedesignHealth. He earlieradvanced fromassociate toVP atOptumVentures and worked inhealthcarestrategy atLEK andanalysis atBlackRock. He studied atDuke andYaleSchoolofPublicHealth.

George Pantazopoulos is an Optum Ventures investmentpartner. His priorwork includes healthcare/consumer/technology M&A advisory atCovingtonAssociates and middlemarketprivateequity atCapitalResourcePartners. He studiedeconomics atTuftsUniversity.

Daisy Cai is a General Partner at B Capital investing across the US and Asia. At B Capital, she has invested in and serves on the board of companies such as Reflection AI, ChipAgents, DreamLabs, EvenUp Law, Apptronik, Knox Systems, Profound Bio (acquired by Genmab in 2024), GeekPlus (IPOed in July 2025), Kaon (FlowGPT), Insilico Medicine (IPOed in Dec 2025), Solino, Tacta System, etc. Daisy has nearly two decades of investment experience. She was formerly a Partner at SoftBank Vision Fund. She held investment director roles at Goldman Sachs and TA Associates. She started her career as a chip architect designer at Advanced Micro Devices (AMD) in Silicon Valley. Daisy earned an MS degree in Electrical Engineering from the University of Southern California and an MBA from Columbia Business School.

Mike Cunningham is an Optum Ventures partner investing in emerginghealthcare companies. His priorinvestmentcareer includes Boston early-stage technology firmPJC and work withentrepreneurs across businessstages. The recordedrank follows the currentown directory ratherthan an unrelatedsimilarlynamedprofessional.

Brandon’s experience as an attorney, investor and entrepreneur spans several asset classes. Prior to B Capital, he worked with TPG Global and was a corporate partner at Kirkland & Ellis. As an entrepreneur, he has started several businesses, including Mytrus, a healthcare technology business that was acquired by Medidata in 2017. He holds a JD from Stanford Law School, an MS in Management Science and Engineering from Stanford University, and a BS in Mathematics and Economics from UCLA. He is based in Los Angeles.

Kate Leonard is Optum Ventures general counsel, previously a lawyer atGoodwinProcter andWilmerHale advisinghealthcare,technology,lifescience,cleantech andretail companies/investors. She graduated fromSuffolkUniversityLawSchool andNortheasternUniversity. This lawyer is distinct from the existing LuminateNY digital-marketing person of thesamename; theirphotographs/careers are not merged.

Dr. Andrew (“Andy”) Jackson is a General Partner and Chief AI Officer at B Capital, where he leads the firm’s global artificial intelligence strategy working across investment, portfolio management and operations teams. He is focused on scaling B Capital’s internal proprietary technology platform and advancing AI capabilities throughout the investment lifecycle to enhance sourcing, diligence, knowledge sharing and founder support. Across the portfolio, he supports companies in their AI adoption journeys and helps build innovative AI products, platforms and technologies that drive long-term value creation. He will also provide technology leadership for AI-driven businesses incubated by B Capital. Andy brings more than 20 years of experience in artificial intelligence, machine learning and data. Prior to joining B Capital, he served as Chief AI Officer at G42, where he partnered with OpenAI to develop country-specific AI strategies and oversaw governance for Stargate UAE, one of the world’s largest AI infrastructure initiatives. He also founded a regional Microsoft-backed AI Foundation focused on advancing AI governance and best practices. Previously, Andy was the founder and CEO of Inception, an AI lab and G24 company that built the most extensive family of open-source AI models in the MENA region. Earlier in his career, he played a key role in expanding Palantir’s presence across the Middle East.

Dean McCausland serves as Optum Ventures CFO. His priorcareer includes two decades as financechief of healthcare andtechnology businesses, supportingcapitalraises,scale and investor-backed exits. He studied atUniversityofOregon andWharton; historicalcompanyfundraising is not Optum fundcash.

Allen Duan is a Venture Partner at B Capital, where he serves on the boards of Fishbrain, Odeko, Winmore and others. He manages B Capital’s investments in multiple Enterprise Tech and AI portfolio companies and spearheads strategic partnerships with leading AI organizations, such as OpenAI. Previously, Allen was Senior Vice President of Corporate Technology at Hearst, overseeing innovation and solutions across mobile, video, advertising, machine learning, voice/audio, data analytics, and other emerging technologies supporting more than 350 businesses. He co-founded Hearst’s first programmatic advertising platform, CoreAudience, and managed over 100 strategic partnerships. Earlier in his career, Allen held senior leadership roles as Corporate Vice President of Strategy and Business Development at Viacom and MTV Networks during the “Jersey Shore” era, and as Senior Director of Corporate Development and M&A at Sony Corporation of America. He began his career at Microsoft, working in product management, business development, and product planning across the MSN, Financial Services, and Mobile & Embedded Devices divisions. Allen started coding as an undergraduate at Harvard, where he earned an AB in Engineering Sciences and Economics. He also holds an MBA from Harvard Business School and is based in New York. Beyond his passion for software and AI, he spends time on his investment in Pied-à-Terre Wines and with his wife running after his daughter and identical twin boys.

Raj Ganguly is a Co-Founder and Co-CEO of B Capital. He is focused on connecting extraordinary entrepreneurs with the people, capital and support needed to drive exponential growth. Prior to founding B Capital, Raj was at Bain Capital, where he invested in technology-driven companies across the U.S. and Asia. He also served as the co-leader of the firm’s global technology initiative. Earlier in his career, Raj worked at McKinsey & Company, Diageo plc and Miradiant, one of the first internet payment startups, which was acquired by J.P. Morgan. Raj earned an MBA from Harvard Business School and a BSE and BAS from the University of Pennsylvania’s Wharton School and School of Engineering and Applied Science. He is based in Los Angeles

Stephen Renfro is Optum Ventures partner and chief operations officer, leading financial,legal and operational functions. A foundingfirmmember, he previously worked in EY transaction-advisory services and with venture-backed businesses. He studied finance/accounting atBostonCollege; currenttitle follows the officialdirectory.

Eduardo Saverin is a Co-Founder and Co-CEO of B Capital. Previously, he was the first investor in and Co-Founder of Facebook. Today, he focuses on investing in the next wave of technological innovation. As an investor and mentor, he has advised and worked closely with an array of companies of all sizes and stages that share a common thread: a passion for people-centric innovation with pan-global ambitions that leverage technology.

Laura Veroneau is a managing partner and founding member of Optum Ventures. Her healthcare experience includes a startup,UnitedHealthGroup,CVSHealth andTransformationCapital. She studied economics/legalstudies atWilliamsCollege and holds an MIT SloanMBA; her published externalBrighamandWomen’s overseer affiliation is not a personalinvestment check.

Larry Renfro leads Optum Ventures as managing partner. He previously led Optum during2011–2018 and held senior UnitedHealthGroup,UnitedHealthcare,Fidelity andAARPServices positions. His investment-management career includes DevonshireFinancialGroup,NewRiver,Allmerica,StateStreet andBostonFinancialDataServices; he earned a WesternKentuckyUniversity bachelor’s degree. His own dated statutory ownership/manager capacities are separate from historical corporateexecutive titles.

Nico Enriquez is a venture capitalist at Future Ventures with an interest in energy, robotics and climate technology. The firm describes an eight-year startup career followed by a Department of Energy Advanced Research Projects Agency fellowship focused on commercialization. He studied cognitive neuroscience at Brown University, earned an MBA at Stanford and completed sustainability finance and analytics training at Columbia.

The organiser of the October 2024 Space Showcase identifies Justin Kingsbury as a Partner at TechFarms Capital, the firm that later announced its GAIN Venture Capital rebrand. That dated professional affiliation is preserved; current GAIN membership and rank are not established by the cited primary source.

Named on GAIN Venture Capital’s public LinkedIn affiliation list. The list establishes a published association but does not disclose his capacity or verify a current operating or legal role.

Tiffany Duke identifies herself as Managing Partner of GAIN Venture Capital in a November 2025 self-authored article on early-stage investing. Her accompanying self-authored post describes a move from Nova Law clients to GAIN. Her published role and legal-to-investment background are retained with current membership qualified.

GAIN’s own company post identifies Mort O’Sullivan III, CPA, as a general partner and recognizes his community service. The published affiliation is retained without expanding his name or inferring a separate investment, current legal office or appointment date.

Kelly Reeser helped source and support early-stage investments, oversee TFC Fund I and manage special-purpose vehicles during leadership roles at TechFarms Capital and GAIN. Her current Palafox Ventures biography describes that leadership as previous and names her as Palafox’s founder and managing partner. Florida company records still list her as a GAIN VC Management LLC manager, and the March 31,2026 Form ADV execution page records her as Managing Director. These statutory and dated affiliations are preserved without claiming a current GAIN operating appointment or a departure date.

General partner listed on TechFarms Capital’s still-published own directory and a registered manager of the renamed GAIN VC Management LLC in Florida company records. The current GAIN website redirects to the legacy site; no unverified appointment date or career biography is added.

Eric de La Fortelle was identified as a Seventure venture partner in Mint Solutions’ July 2014 financing announcement and joined its board as part of that investment. His quotation discusses improving hospital medication delivery; present board tenure is unverified.

Tim Wouters is published as MedEye’s Director Customer Value in its legacy Dutch and English directories. Further career history and current tenure are not established by the available issuer profile. Current tenure is unverified beyond the published source.

Gísli Hardarson is published in MedEye’s research-and-development team. His issuer biography describes computer-science studies at the University of Skövde and more than 20 years of healthcare-software development, including electronic patient records and prescribing systems. Current tenure is unverified beyond the published source.

Bastian Teichert is published as MedEye’s deployment specialist. His issuer biography describes14 years of registered-nursing experience across hospital wards and familiarity with nursing technologies. Current tenure is unverified beyond the published source.

Adda Birna Hjálmarsdóttir is published as a pharmacist at MedEye. Her issuer biography describes pharmacy training and healthcare-IT, pharmacy and quality experience, with responsibility for medication handling and related information quality. Current tenure is unverified beyond the published source.

Magni Mortensen is published as MedEye’s senior developer. His issuer biography describes more than 20 years in software design and development across industries, including earlier architecture and information-security work at Íslandsbanki. Current tenure is unverified beyond the published source.

Hjörtur Sturluson is published in MedEye’s research-and-development team with responsibility for quality assurance. His issuer biography describes electrical and computer engineering studies at the University of Iceland and software development for hospital information systems. Current tenure is unverified beyond the published source.

Janneke Vos is published as MedEye’s marketing manager. Her issuer biography describes earlier healthcare-IT marketing work at ChipSoft and D&A Medical Group and responsibility for Dutch marketing strategy and activities. Current tenure is unverified beyond the published source.

Haukur Sigurðarson is published in MedEye’s research-and-development team. His issuer biography describes astronomy work and a radio-and-space-science master’s degree at Chalmers University of Technology, with expertise in computer-vision data analysis. Current tenure is unverified beyond the published source.

Margrét Una Kjartansdóttir is published in MedEye’s research-and-development team. Her issuer biography describes information-sciences training at Columbia University and work on machine-learning projects. Current tenure is unverified beyond the published source.

Gertjan de Bijl is published in MedEye’s technical-coordination team. His issuer biography describes healthcare experience as a clinical pharmaceutical and toxicological analyst, followed by technical implementation of electronic-prescribing software. Current tenure is unverified beyond the published source.

Bjarni Ívarsson is published as MedEye’s lead developer. His issuer biography describes programming and development-team leadership, overseeing software development, reliability and security for demanding hospital environments. Current tenure is unverified beyond the published source.

Ívar Helgason co-founded MedEye and is published as product owner in the issuer’s legacy directory. A physician with software and hardware experience, he developed the medication-verification concept while studying at MIT and Harvard Medical School and previously founded a decision-support company acquired by deCODE Genetics. Current tenure is unverified beyond the published source.

Gauti Reynisson co-founded MedEye and is published as its CEO in the issuer’s legacy directory and July 2024 financing release. His biography describes earlier electronic-prescribing development and hospital-IT sales and development leadership at Theriak and CTP, an MIT Sloan MBA and computer-science training. Current tenure is unverified beyond the published source.

Steven Robert Lapkoff is listed as E1 Ventures LLC’s chief compliance officer fromJune2026 in its September8,2026 FormADV. His own professional profile identifies an ACA Group affiliation, a Pace University School of Law degree and New York attorney credentials. This regulatory role does not establish full-time investment-partner employment, portfolio decision authority or a personal investment. No authentic portrait bytes were verified during this audit, and an unrelated namesake photograph is not substituted.

Doug Cassidy works with health systems, academic medical centers and life-sciences organizations. His prior leadership includes Deep 6 AI and Manifold AI, alongside healthcare software, medical-record and cancer-detection work.

Ross Cantor leads commercialization and strategic partnerships across health systems, laboratories and life-sciences organizations. His earlier work includes commercializing Proscia’s real-world data business.

Suzy Bureau leads product development for Health Universe. Her earlier work includes product leadership at CoverMyMeds, iyO and Thirty Madison, spanning healthcare workflows and consumer products.

Jim Muir leads technical strategy and software engineering. His earlier work includes voice AI at iyO, mobile engineering at Rise Science, and healthcare-product engineering at CoverMyMeds.

Doug Fridsma is a physician and biomedical informatics specialist. His earlier leadership includes AMIA and the US Office of the National Coordinator for Health Information Technology, with work on health-data standards and interoperability.

Dan Caron founded Health Universe to develop infrastructure for deploying AI agents in healthcare. His earlier work includes co-founding Arrive Health, a prescription-optimization business.

Shruti Kumar is vice president at Tusk Ventures, leading sourcing and due diligence. Her primary biography describes prior investing at 01 Advisors and Long Arc Capital, operating experience at GlossGenius and technology investment banking at Citigroup. She holds a New York University finance degree and is based in New York.

David Kolata is a Tusk Ventures adviser working on policy and regulatory growth strategy. He has served as vice president of policy at Sealed and previously led Citizens Utility Board, including Illinois energy-policy initiatives. He holds Notre Dame, University of Toronto and Vanderbilt degrees. His work with outside clients is not treated as an investment by the platform.

Christina Esposito advises Tusk Ventures on government relations and regulation. Her biography describes work on travel, gaming, labour, energy and other policy areas and prior New York State digital-project and New York City media-office roles. Her current published advisory affiliation is not recast as a fund-manager position.

Gabby Goldberg is published as operations manager of SYNthesis Research and its investee companies Anaxis Pharma and Catalyst Therapeutics. Her biography describes translational immunology and industry-linked preclinical development experience; she is distinct from venture investor Gaby Goldberg.

Ueli Nachbur is Anaxis’s published lead biologist. His research background covers inflammatory signalling, cell death and preclinical disease models.

Peter Czabotar is Anaxis’s published lead structural biologist. His work examines proteins regulating cell-death signalling and uses structure-based methods to develop potential therapeutics.

Jean-Marc Garnier is Anaxis’s published lead medicinal chemist. His biography describes medicinal-chemistry work on epigenetic and necroptosis inhibitors.

Helene Jousset, identified in the biography as Hélène Jousset Sabroux, is Anaxis’s published head of screening. Her background includes high-throughput drug-discovery screening in academic and pharmaceutical settings.

James Murphy is published as Anaxis Pharma’s director of biology. Its biography identifies the WEHI cell-death researcher who studies MLKL and necroptosis, distinct from the existing Forum Ventures managing-partner identity.

Xian Bu is an Anaxis board member and medicinal chemist. His published biography describes drug-discovery and contract-research management experience.

Peter Colman is published as an Anaxis board member. A structural biologist, his biography describes influenza neuraminidase research and prior biotechnology board work.

Guillaume Lessene is published as Anaxis’s chief scientific officer. His research and medicinal-chemistry background includes targeting apoptotic and necroptotic cell-death pathways.

Cory Epstein is listed as senior vice president of communications in Tusk Ventures’ roster. His biography clarifies that his executive post is at parent Tusk Holdings and that he provides communications advice to Tusk Ventures companies. He previously led communications at Transportation Alternatives and worked at Lyft, including Citi Bike. He attended Vassar. The parent employer qualification is retained.

Tim Sullivan advises Tusk Ventures on economic development and public-sector partnerships. He led the New Jersey Economic Development Authority from 2018 to 2025 and previously held Connecticut economic-development and New York City deputy-mayoral staff roles. His government programme budgets are not attributed as venture-fund capital or personal investments.

Anna von Finckenstein is communications associate at Tusk Ventures. She previously worked at Aptos Labs on public relations and executive communications and at communications consultancies supporting regulated finance and technology clients. She holds a McGill degree in modern European history with political science studies.

Ed Manzi is a Tusk Ventures adviser focused on state policy and healthcare regulatory strategy, including coverage and reimbursement. His earlier work includes WebMD healthcare operations, Everly Health channel strategy and investing at Social Impact Capital. He co-founded the public discussion programme UNMUTED. He holds Harvard and Northeastern degrees and is a licensed CPA. His role is advisory, not an assumed partner or personal investor.

Michael LaCerda, displayed as Mike LaCerda in the directory, is chief financial officer of Tusk Venture Partners. His primary biography describes responsibility for fund finance, accounting, reporting, planning, valuation oversight and compliance. The firm’s 2022 founder announcement identifies prior alternative-asset finance experience at BlackRock, Blackstone and KKR. The Mike/Michael name variant is established by the same named team page and biography.

Quinn Shean is listed on Tusk Venture Partners’ platform team. Her primary biography describes regulatory strategy, policy development, communications and partnerships for companies operating in regulated markets. She helps translate regulatory challenges into execution strategies. She is absent from the current separate Tusk Ventures roster; that affiliation is not inferred.

Marla Kanemitsu is an adviser at Tusk Ventures and a named platform affiliate at Tusk Venture Partners. She advises regulated businesses on legal, growth and policy strategy, including fintech and e-commerce. She previously practiced law as a partner and handled complex commercial disputes and regulatory risk. She holds a Cornell law degree and a University of Texas undergraduate degree. Current advisory roles are distinguished from any inferred permanent investment employment.

Cynthia Matar leads communications and public affairs at Tusk Ventures and is separately listed on Tusk Venture Partners’ platform team. Her work connects positioning, media and policy for emerging technology businesses. Her own biography describes prior venture-platform operating work, including chief-of-staff experience at a neurotechnology-focused VC firm. She holds a Pace University business degree. Titles are tied to each publisher’s roster rather than assuming the two operating platforms are identical.

Bob Greenlee is president of Tusk Ventures and a regulatory member of the Tusk Venture Partners platform team. His work spans healthcare, financial services, energy, education and manufacturing. He formerly served as Illinois deputy governor and deputy director of its budget office and practiced law. He holds Yale and University of Chicago degrees and teaches non-market strategies at Columbia. Both firms’ own pages explicitly describe his portfolio-company regulatory work.

John Hooie is a publicly listed member of Tusk Venture Partners’ investment team. His biography describes prior investing work at Forté Ventures, including collaboration with strategic corporate investors across technology industries. His current named manager affiliation is retained without inventing a managing-partner title or membership in the separate Tusk Ventures roster.

Jordan Nof is co-founder and managing partner of Tusk Venture Partners. His own biography identifies investment work in Lemonade, FanDuel and Coinbase and board affiliations with Alma, Wheel, Sunday and Elaborate. Before Tusk he worked on Blackstone’s corporate venture portfolio and in institutional investment management at AllianceBernstein. He holds a Rollins MBA and Florida State finance degree and teaches at Columbia. The newer Tusk Ventures public roster does not list him; no new-platform role is inferred.

Bradley Tusk co-founded Tusk Venture Partners with Jordan Nof and leads Tusk Ventures as founder and CEO. His career includes Bloomberg’s 2009 mayoral campaign and service as Illinois deputy governor. His 2025 founder announcement distinguishes traditional venture funds from the renewed equity-for-regulatory-services platform, which can also make small balance-sheet investments and deal-specific SPVs. He founded Tusk Strategies and leads Tusk Holdings, identified by the current team page as the parent of Tusk Ventures.

Kylee Haller — Synapticure publishes the following professional biography and affiliation: is a speech-language pathologist specializing in neurodegenerative diseases, with extensive experience treating ALS, Parkinson's, and other neurologic conditions. She is dedicated to improving patient quality of life through personalized assessment, therapy, and assistive technology integration. VA Pittsburgh Healthcare System (Speech-Language Pathology) Graduate - University of Minnesota (Speech-Language Pathology) Undergraduate - University of Minnesota (Speech-Language-Hearing Sciences & Neuroscience) American Speech-Language-Hearing Association (ASHA) Certificate of Clinical Competence in Speech-Language Pathology (ASHA) Huntington’s Study Group (HSG) Rehab Committee, Member Kylee Haller is a speech-language pathologist with advanced training in neurodegenerative diseases. She completed her undergraduate and graduate degrees in speech-language pathology at the University of Minnesota. During her fellowship at the VA Pittsburgh Healthcare System, Kylee gained specialized experience treating a range of neurologic conditions in the veteran population, with a focus on ALS and Parkinson's disease through the PADRECC program. Prior to joining Synapticure, Kylee served as the sole speech-language pathologist at the Penn Medicine Movement Disorders Clinic, where she worked with multidisciplinary teams to treat patients with ALS, Parkinson’s disease, atypical parkinsonism, Huntington’s disease, and ataxia. She also collaborated closely with the Penn Memory and FTD Center, further refining her expertise in cognitive and motor disorders. Kylee is dedicated to providing personalized assessment and treatment for speech, language, cognition, swallowing, and the use of alternative and augmentative communication (AAC) devices. With a strong focus on functional outcomes, she is committed to improving her patient's quality of life through innovative therapy and the integration of assistive technologies. Invited Presentations ‍ - “Communication with a Tracheostomy – The Role of Speech-Language Pathology”, April 2022, PEEPS Talking PAP Conference (International – Virtual) - “Evaluation of cognitive-communication deficits following treatment of primary brain tumors”, October 2017, Mayo Clinic Radiation Oncology Grand Rounds (National – Rochester, MN) ‍ Presentations at National Meetings ‍ - “Cognitive-linguistic deficits following treatment of brain tumors: Results of a prospective pilot study”, October 2018, American Society of Radiation Oncology, San Antonio, TX. ‍ American Speech-Language-Hearing Association (ASHA) Certificate of Clinical Competence in Speech-Language Pathology (ASHA) Huntington’s Study Group (HSG) Rehab Committee, Member Current directory role is Speech-Language Pathologist.

Lisa Diamond — Synapticure publishes the following professional biography and affiliation: Dr. is an esteemed psychiatrist, former Chief of Psychiatry at notable hospitals, now a leading telehealth consultant and Medical Director shaping modern mental health policies New York University Medical school - Columbia University Undergraduate - Yale University ‍ Lisa Diamond, MD is a graduate of Columbia University, College of Physicians and Surgeons, and attended Yale University for her undergraduate studies, where she graduated Magna Cum Laude with a Bachelor of Arts degree in Psychology. Dr Diamond trained at New York University in the department of Psychiatry during her residency. Dr Diamond started a private practice in New York City, and continued in private practice when she moved to New Milford, CT. In 1998, she become Chief of Psychiatry at New Milford Hospital where she expanded the staff to include Advanced Practice Nurse Practitioners for the first time. After 12 years at New Milford Hospital, Dr Diamond left to become Chief of Psychiatry at Charlotte Hungerford Hospital, which is part of Hartford Healthcare Corporation. At Charlotte Hungerford, her responsibilities included oversight of a 17 bed inpatient unit, extensive adult outpatient services, a partial hospital program, a dual diagnosis intensive outpatient program, and the Center for Youth and Families. Currently, Dr Diamond is a consultant to Charlotte Hungerford Hospital, and, in addition,  is working remotely via telehealth. Her telehealth work includes both direct patient care, as well as work in Medical director positions at Wellbrook Health, LinqCare and Catholic Charities, to guide development of policies and procedures. Current directory role is Psychiatrist.

Jennifer Green — Synapticure publishes the following professional biography and affiliation: With more than 17 years of clinical experience, specializes in Parkinson’s disease and movement disorders, focusing on thoughtful care that supports both neurologic and emotional well-being. East Carolina University, Greenville, NC (Bachelor of Science in Multidisciplinary Studies with a concentration in Neuroscience) Honors: General Education Honors, Cum Laude, Order of Omega East Carolina University, Greenville, NC (Master of Science in Physician Assistant Studies) American Academy of Physician Assistants (AAPA), Member Movement Disorder Society, Member American Academy of Neurology, Member Parkinson’s Study Group, Member Huntington Study Group, Member Jennifer Green, PA-C is a physician assistant specializing in the care of patients with Parkinson’s disease and other movement disorders, with over 17 years of clinical experience, including 13 years focused specifically on movement disorders. Born and raised in the Appalachian Mountains of North Carolina, Jennifer values community, authenticity, and caring for people as individuals—not just diagnoses. After completing her education, she settled in the Triad region of North Carolina, where she lives with her two children. Jennifer takes a holistic approach to neurologic care, with a particular interest in the connection between neurologic disease and mental health. She believes that emotional well-being, confidence, and feeling understood play a critical role in quality of life, especially for patients navigating chronic neurologic conditions. Her clinical style emphasizes education, thoughtful medication adjustments, and helping patients feel supported and confident in their care plan. Through Synapticure’s virtual care model, Jennifer provides expert neurology care directly to patients in their homes, working closely with caregivers to address both motor and non-motor symptoms, reduce symptom fluctuations, and support long-term quality of life. Outside of work, Jennifer spends most of her time with her children and enjoys reading personal growth literature and watching true crime documentaries. American Academy of Physician Assistants (AAPA), Member Movement Disorder Society, Member American Academy of Neurology, Member Parkinson’s Study Group, Member Huntington Study Group, Member Current directory role is Physician Assistant, Movement Disorders.

April Stowers — Synapticure publishes the following professional biography and affiliation: With over 25 years of experience across specialties like cardiology and neurology, April is a dedicated nurse practitioner, educator, and certified dementia practitioner. Beyond her professional work as an adjunct professor and guest lecturer, she is a devoted West Virginia Mountaineer and Girl Scout co-leader who enjoys life with her family and dog. Purdue University, West Lafayette, IN Master of Science in Nursing West Virginia University, Morgantown, WV Bachelor of Science in Nursing American Association of s Florida Nurse Practitioner Network I am passionate about medical education. I have worked as an adjunct professor at Florida Gulf Coast University, as well as a guest lecturer for several other universities, medical programs, and conferences. With over 25 years of experience in the medical industry, I have expertise in various medical specialties, including cardiology, vascular surgery, primary care, and neurology. I am most passionate about working with Alzheimer’s patients and families, having expanded my knowledge base further to become a certified dementia practitioner. In addition to working as an educator and a nurse practitioner, I am an avid reader, WVU Mountaineer, and Star Wars fanatic. I spend my free time with my husband, son, daughter, and dog. My daughter and I are active in Girl Scouts, where I am a co-leader, and she is currently working on her Gold Award. ‍ American Association of Nurse Practitioners Florida Nurse Practitioner Network Current directory role is Nurse Practitioner.

Ashley Tanton — Synapticure publishes the following professional biography and affiliation: Dr. , a clinical neuropsychologist specializing in various neurological and psychological disorders, joined Synapticure in 2024, bringing extensive experience from her work at VA Medical Centers and her diverse educational background. Phoenix VA Medical Center (Neuropsychology) Graduate- Alliant International University Undergraduate- American University Dr. Ashley Tanton joined Synapticure in 2024, providing psychotherapy and neuropsychology services to patients and their families. She is a clinical neuropsychologist and her areas of specialization include cognitive impairment, neurodegenerative disorders (i.e., dementia), traumatic brain injury, stroke, movement disorders (i.e., Parkinson’s Disease), medical diagnoses, mood disorders, posttraumatic stress disorder, attention-deficit/hyperactivity disorder, and learning disabilities. Dr. Tanton completed her undergraduate studies in international studies at American University in Washington, DC. Following a brief career in legal marketing, she decided to pursue her passion for psychology by completing a doctoral degree in Clinical Psychology. In addition to a Psy.D., she also holds an M.A. in Clinical Forensic Psychology and an M.A. in Health Psychology. Dr. Tanton’s clinical training included a predoctoral practica at the Northern California VA Medical Center specializing in neuropsychology, a predoctoral internship at the Gulf Coast VA Medical Center specializing in neuropsychology, and a two-year neuropsychology postdoctoral residency at the Phoenix VA Medical Center. Most recently, Dr. Tanton served as the sole clinical neuropsychologist for the West Palm Beach VA Medical Center, where she provided neuropsychological services for our nation’s heroes and supervised psychology interns in the administration and interpretation of neuropsychological evaluations. In early 2024, Dr. Tanton decided to devote her time to private practice full-time. In her free time, Dr. Tanton enjoys spending time with her husband and two fur babies, reading, traveling, baking, and being near the water. Current directory role is NeuroPsychologist.

Caryn Glosch — Synapticure publishes the following professional biography and affiliation: Dr. Glosch is a clinical psychologist specializing in neuropsychological evaluation, dementia care, and psychotherapy, blending expertise in CBT, ACT, and neuropsychology to support patients and caregivers with clarity and compassion. VA Puget Sound Healthcare System - Neurocognitive Disorders Across the Lifespan Track Louis Stokes VA Medical Center - Health Psychology - Geropychology Track University of Houston - PhD in Clinical Psychology - Neuropsychology emphasis Purdue University- BA in Psychology Dr. Glosch is a clinical psychologist with 15 years of experience in neuropsychological evaluation of dementia, caregiver support, and psychotherapy. An integral part of her career is ensuring that patients and caregivers understand the information given to them and empowering them to manage stress with resilience and dignity. Dr. Glosch earned a Bachelor’s degree in Psychology from Purdue University and a PhD in Clinical Neuropsychology from the University of Houston. She completed a Neuropsychology internship at the VA Pittsburgh Healthcare System, a Neuropsychology post-doctoral fellowship at the VA Puget Sound Healthcare System, and a Geropsychology post-doctoral fellowship at the Louis Stokes Cleveland VA Medical Center. Over the past several years, Dr. Glosch has incorporated her background in neuropsychology into her psychotherapeutic work, helping patients understand how cognitive/neurological issues impact mood and vice versa. She has combined this unique perspective with extensive training in Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT). In her free time, Dr. Glosch enjoys listening to audiobooks while cooking dishes from all over the world, photography, and traveling with her husband. Current directory role is Neuropsychologist.

Tracey Meyers — Synapticure publishes the following professional biography and affiliation: Dr. is a seasoned clinical neuropsychologist at Synapticure, leveraging over 25 years of experience in brain injury, neurodegeneration, and mental health, and is a published author and leader in integrative wellness practices like yoga and mindfulness. University of Miami - Jackson Memorial Medical Center (Neuropsychology/Geropsychology) Graduate - Florida Tech Undergraduate - Skidmore College St. Francis Hospital, Hartford, CT The Rehabilitation Hospital of Connecticut - Hartford, CT Dr. Tracey Meyers joined Synapticure in 2023, providing psychotherapy and neuropsychology services to patients and their families. She is a clinical neuropsychologist with over 25 years of experience working in with people living with traumatic brain injury and stroke along with other neurodegenerative disorders. She also has worked extensively with people living with mental health and addictions challenges in psychiatric clinics and hospital settings. In addition to her neuropsychological assessment and psychotherapy experience, Dr. Meyers has a strong commitment to integrative medicine for mental health and wellness and leads mindfulness and yoga programs for groups, individuals, and professionals in the workplace. Dr. Meyers graduated from Skidmore College in 1992 and completed her doctorate in clinical psychology from Florida Tech in 1997. She completed her internship in neuropsychology at the Miami VA and her postdoctoral fellowship in neuropsychology and geropsychology  at the University of Miami/Jackson Memorial Medical Center. She is a member of the American Psychological Association, the National Association of Neuropsychology, the International Neuropsychological Society, and the National Register of Healthcare Providers in Psychology. In addition, she is an advanced yoga teacher, certified C-IAYT yoga therapist, MBSR and Mindful self-compassion instructor, Breath-Body-Mind teacher, and iRest teacher. Dr. Meyers has authored several publications and book chapters around neuropsychological assessment, autism spectrum disorders, behavioral treatment for different mental health conditions, yoga for addiction, and has written a book on yoga and mental health, Yin Yoga Therapy (Singing Dragon, 2022). Meyers, T. (2022). Yin Yoga Therapy and Mental Health . Singing Dragon: London. Meyers, T . (2021). Relationships in Yoga Therapy: Developing Collaboration within a healing presence. In Yoga Therapy Foundations, Tools, and Practice edited by Laurie Hyland Robertson and Diane Finlayson.  Singing Dragon: London. Meyers-Sondik , T.M.. (2019). Pain, Addiction, and Yoga. In Yoga and Science in Pain Care: Treating the Person in Pain edited by Neil Pearson, Shelly Prosko, Marlysa Sullivan, Jessica Kingsley:  London. Tolisano, P, Meyers - Sondik, T.M, Dike, C, (2017). A positive behavioral approach for aggression in forensic psychiatric settings.  The Journal of the American Academy of Psychiatry and the Law, 45 (vol 1); p.31-39. Meyers-Sondik , T.M. (2016) . Positive Behavioral Supports for Managing Violence Risk in an Inpatient Forensic Setting .  In  Forensic Psychiatry and Psychology Practice: Bearing Witness to Change edited by Drs. Ezra Griffith, Michael Norko, Alec Buchanan, Madelon Baranoski and Howard Zoana, CRC Press: London. Matuskey, D & Meyers-Sondik, T.M . (2014)  Case  Report:  Memory reconsolidation paradigm to treat aggression and self-injurious behaviors.  Journal of Clinical Psychopharmacology (vol 35) p. 1-2. Hillbrand, M.& Meyers-Sondik, T.M. (2012) Commentary: Treatment and Violence Risk Mitigation in High-Functioning Autism Spectrum Individuals. The Journal of the American Academy of Psychiatry and the Law, 40 (vol 2); p.191-192. Gass, C.G., Luis, C.A., Meyers, T.L ., and Kuljis, R.  (1998).  Familial Creutzfeldt-Jakob Disease:  A Neuropsychological Case Study.  Archives of Clinical Neuropsychology. 15 (2), 165-175. Peake, T.H., Meyers, T.L ., & Duenke, S. (1997). Options for brief psychotherapy: Cognitive and psychodynamic variations. Journal of Mental Health 6 ( 3) 217-235. St. Francis Hospital, Hartford, CT The Rehabilitation Hospital of Connecticut - Hartford, CT Current directory role is Neuropsychologist.

Monica Lavian — Synapticure publishes the following professional biography and affiliation: Dr. is a fellowship-trained neurologist who specializes in caring for patients living with neuromuscular diagnoses like ALS University of California, Irvine (Neurology) University of California, Irvine  (Neuromuscular Medicine) ‍ Medical school - Western University of Health Sciences, College of Osteopathic Medicine of the Pacific Undergraduate - University of California, Irvine (BS, Biological Sciences) American Academy of Neurology (AAN): Member Dr. Monica Lavian completed both her Neurology residency and Neuromuscular fellowship at the University of California, Irvine. She is a Member of the American Academy of Neurology. Dr. Lavian is especially enthusiastic about the field’s ever-expanding arsenal of tests and treatments for neurologic diseases. In her words, “I was drawn to Synapticure not only because it provides comprehensive care for our patients in a convenient manner, but also Synapticure is at the forefront of ever expanding diagnostic and treatment advancements in Neuromuscular diseases with offering genetic testing, comprehensive treatment plans, and overall access for our patients so they can experience top notch comprehensive care.” ‍ Tim Lai MD, Monica Lavian DO , Lama Al-Khoury MD, Shuichi Suzuki MD, Wengui Yu MD, PhD. Individualized Time Window for Endovascular Therapy in Acute Basilar Artery Occlusion: Case Report and Literature Review.  Neurological Cases.  December 2016; 3(2): 1-4. Lavian, M ., Goyal, N., Mozaffar, T. “Sporadic inclusion body myositis misdiagnosed as granulomatous myositis.” Neuromuscular Disorders. September 2016. 25, S239 - S240. Article in Press Huaiyu Gu, Shaojuan Amy Jiang, Jorge M. Campusano, Jorge Iniguez, Hailing Su, Andy An Hoang, Monica Lavian , Xicui Sun, and Diane K. O'Dowd. “Ca v 2-Type Calcium Channels Encoded by cac Regulate AP-Independent Neurotransmitter Release at Cholinergic Synapses in Adult Drosophila Brain”. J Neurophysiol. 2009 January; 101(1): 42–53. American Academy of Neurology (AAN): Member Current directory role is Neuromuscular Neurologist.

Anuj Dhir — Synapticure publishes the following professional biography and affiliation: Dr. is a fellowship-trained neurologist who specializes in caring for patients living with neuromuscular diagnoses like ALS. Emory University School of Medicine (Neurology) ‍ Emory University School of Medicine (Clinical Neurophysiology, focus in EMG/Neuromuscular) Medical school - Emory University School of Medicine (MD) Undergraduate - University of Georgia (BS Biology, minor Spanish) American Academy of Neurology (AAN): Member Dr. Anuj Dhir completed both his residency and fellowship at Emory University, focusing on neurology during his residency and on EMG/neuromuscular during his fellowship. He is a Member of the American Academy of Neurology. Dr. Dhir is passionate about helping patients understand the nuances of their diagnoses and what is happening in their “fascinatingly complex neurologic system.” He was initially drawn to Synapticure for its commitment to democratizing access to specialized care. Having practiced medicine internationally in resource-limited settings (Tanzania, Indian Himalayas), access to adequate healthcare is a challenge he cares about deeply, and so he welcomes the opportunity to support patients across the country access the care they deserve. Radiographic Improvement of Larval Cysts in Neurocysticercosis. David R. Landzberg, Anuj Dhir, Dinesh V Jillella. Annals of Neurology 2021 Feb 1 A, not so uncommon, uncommon cause of acquired epilepsy: A Case Report. Valerie Jeanneret 1 , Anuj Dhir 1 . Department of Neurology, Emory University School of Medicine; Atlanta, GA, USA. (March 9 th , 2019) American Academy of Neurology (AAN): Member Current directory role is Neuromuscular Neurologist.

Danielle Geraldi-Samara — Synapticure publishes the following professional biography and affiliation: Synapticure’s ALS care team is led by Dr. , who has has diagnosed and treated ALS patients for over fifteen years. The Mount Sinai School of Medicine (Neurology) The Mount Sinai School of Medicine (Clinical Neurophysiology with Neuromuscular/EMG focus) Medical school - State University of New York at Syracuse Undergraduate - Georgetown University (BS Biology, minor Philosophy) member American Academy of Neurology (AAN) member American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Yu, Edward H, Geraldi-Samara D. Pharyngeal-Cervico-Brachial/Miller Fisher Overlap  Syndrome With Infliximab Exposure. J Clin Neuromuscular Disease. 2020 March; 21(3): 157-158 Salem A, Shah N, Geraldi-Samara D, Elangovan N, Kryzak M. Late Onset Bipolar Disorder  Type I. Cereus. 2018 Aug 31;10(8) him Cracking the Crack Dance: A Case Report on Cocaine-induced Choreoathetosis Poster at the Chest Annual Meeting Toronto, Canada 2017 Reduced Heart Rate Variability in Familial Amyloidosis Due to the TTR Leu 64 Mutation Abstract at the 58 th annual AAN meeting, San Diego, CA 2007 member American Academy of Neurology (AAN) member American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Current directory role is Neuromuscular Director.

Jessica Tate — Synapticure publishes the following professional biography and affiliation: Dr. Tate is a Movement Disorders specialist passionate about patient-centered care and expanding access to expert treatment. She enjoys birding, reading, and family time in North Carolina. Wake Forest University School of Medicine (Neurology) Wake Forest University School of Medicine (Movement Disorders) Doctor of Medicine, West Virginia University School of Medicine Bachelor’s of Science in Biology, College of William & Mary American Academy of Neurology International Parkinson and Movement Disorder Society Dr. Tate has been working as an academic Movement Disorders specialist since 2014 and has extensive experience caring for patients with Parkinson’s Disease, other forms of Parkinsonism, and Huntington’s Disease. She is passionate about educating patients and care partners and involving them in shared decision-making about treatment options. She is excited about expanding access to subspecialty expertise with Synapticure. ‍ Dr. Tate grew up in small towns in West Virginia and Virginia. She currently lives in North Carolina with her husband and two children. In her spare time, she loves reading and spending time outside enjoying the natural world, especially birding. American Academy of Neurology International Parkinson and Movement Disorder Society Current directory role is Movement Disorders Specialist.

Jaime Hatcher-Martin — Synapticure publishes the following professional biography and affiliation: Synapticure’s Movement Disorders team is led by Dr. , a Movement Disorder Specialist who has cared for people with neurodegenerative diseases such as Parkinson’s and Huntington’s Disease for over a decade. Emory University School of Medicine (Neurology) Emory University School of Medicine (Movement Disorders) Medical school - Emory University School of Medicine (MD/PhD) Undergraduate - University of South Florida (BS Biology, minor Gerontology) 2023-current: Huntington Study Group (HSG) Education Committee 2023-current: Huntington Study Group (HSG) Credentialing Committee 2021-current: American Academy of Neurology Medical Economics and Practice (MEP) Telehealth Subcommittee 2019-current: Huntington Study Group (HSG) Family Day Planning Committee 2017-current: International Parkinson’s Disease and Movement Disorders Society Telemedicine Work Group Synapticure’s Parkinson’s care team is led by neurologist Dr. Jaime Hatcher-Martin. For over a decade, Dr. Martin has been caring for people with neurodegenerative diseases, specializing in movement disorders like Parkinson’s. With this insight, she recognized the unique burdens on her Parkinson’s patients. Coupled with the fact that many people living with Parkinson’s have no access to specialists, she became a leading advocate to partner telemedicine with expert neurological care. Prior to joining Synapticure, Dr. Martin practiced at Emory University where she started her own telemedicine clinic for patients with movement disorders in Georgia in 2016, and later at SOC Telemed (now Access Telecare). She is a Fellow of the American Academy of Neurology, served as co-Chair for their Telemedicine Workgroup, where she co-authored their practice guidelines. She also serves on the Telemedicine Study Group for the International Parkinson and Movement Disorder Society and serves on several committees for the Huntington Study Group. Dr. Martin continues to be involved in research related to understanding the toxic exposures that cause or contribute to the meteoric rise in the incidence of Parkinson's Disease. Hatcher-Martin JM , McKay J, Sommerfeld B, Howell J, Goldstein F, Factor SA. “Cerebrospinal fluid biomarkers in Parkinson's disease with freezing of gait: an exploratory analysis.” 2021. NPJ Parkinsons Dis. 29(7): 105. Hatcher-Martin JM and Factor SA. 2016. Freezing of Gait: A Rare Delayed Complication of Whole Brain Radiation. Parkinsonism Relat Disord. 29:129-130. Factor SA, Hatcher-Martin JM , Morse AS, Nocera JR, Revuelta FJ. 2016. Freezing of gait that disappears: Should there be rest before Rehab? Parkinsonism Relat Disord. 28:169-170. Hatcher-Martin JM, Shaikh AG, Factor SA. 2015. Chapter 22: Stereotypies in Parkinson’s Disease and Movement Disorders. Jankovic J and Tolosa E (eds). Wolters Kluwer. pp 233-39. Hatcher-Martin JM , Gearing M, Steenland K, Levey AI, Miller GW, Pennell KD. 2012. Association between polychlorinated biphenyls and Parkinson's disease neuropathology. Neurotoxicology. 33 (5): 1298-1304. Hatcher JM , Miller GW, Jones DP, Pennell KD. 2008. Chapter 16: Neurotoxicity of manufactured nanoparticles, in Nanoscience and Nanotechnology: Environmental and Health Impact. Grassian, VH (ed). John Wiley & Sons; 405-428. Hatcher JM , Pennell KD, Miller GW. 2008. Parkinson’s diseases and pesticides: a toxicological perspective. Trends Pharmacol Sci. 29 (6): 322-329. Hatcher JM , Richardson JR, Guillot TS, McCormack AL, Di Monte DA, Jones DP, Gearing M, Levey AI, Pennell KD, Miller GW. 2007. Elevated levels of the pesticide dieldrin are associated with Parkinson’s disease. Experimental Neurology. 204 (2): 619-630. Hatcher JM , Delea KC, Richardson JR, Pennell KD, Miller GW. 2008. Disruption of dopamine transport by DDT and its metabolites. Neurotoxicology. 29 (4): 682-690. Hatcher-Martin JM , Anderson EA, Busis NA, Bove RM, Cohen BH, Fritz JV, Jones EC, Shook SJ, Wolf RA. AAN Telehealth Position Statement. 2021. Neurology. 98(7): 334-339. Cubo E, Hassan A, Bloem BR, Mari Z… Hatcher-Martin JM … on behalf of the International Parkinson and Movement Disorder Society (MDS) Telemedicine Work Group. 2020. Implementation of Telemedicine for Urgent and Ongoing Healthcare for Patients with Parkinson’s Disease During the COVID-19 Pandemic: New Expectations for the Future. J Parkinsons Dis. 10(3):911-913. Hatcher-Martin JM , Adams JL, Anderson ER, Bove R, Burrus TM, Chehrenama M, Dolan O'Brien M, Eliashiv DS, Erten-Lyons D, Giesser BS, Moo LR, Narayanaswami P, Rossi MA, Soni M, Tariq N, Tsao JW, Vargas BB, Vota SA, Wessels SR, Planalp H, Govindarajan R. 2020. Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology Update. Neurology. 94(1):30-38. Ben-Pazi H, Browne P, Chan P, Cubo E, Guttman M, Hassan A, Hatcher-Martin JM , Mari Z, Moukheiber E, Okubadejo NU, Shalash A, and the International Parkinson and Movement Disorder Society Telemedicine Task Force. 2018. The Promise of Telemedicine for Movement Disorders: An Interdisciplinary Approach. Invited article for Movement Disorders. Curr Neurol Neurosci Rep. 18(5):26. Hu WT, Howell JC, Ozturk T, Gangishetti U, Kollhoff AL, Hatcher-Martin JM , Anderson AM, Tyor WR. 2019. Front Immunol. 10:480. Hatcher-Martin JM, Armstrong KA, Scorr LM, Factor SA. 2016. Propranolol therapy for Tardive Dyskinesia: A retrospective examination. Parkinsonism Relat Disord. 32:124-126. Arendash GW. King DL. Gordon MN. Morgan D. Hatcher JM . Hope CE. Diamond DM. 2001. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Research. 891(1-2):42-53. Arendash GW. Gordon MN. Diamond DM. Austin LA. Hatcher JM. Jantzen P. DiCarlo G. Wilcock D. Morgan D. 2001. Behavioral assessment of Alzheimer's transgenic mice following long-term A-beta vaccination: task specificity and correlations between A-beta deposition and spatial memory. DNA & Cell Biology. 20(11):737-44. Gordon MN. King DL. Diamond DM. Jantzen PT. Boyett KV. Hope CE. Hatcher JM , DiCarlo G. Gottschall WP. Morgan D. Arendash GW. 2001. Correlation between cognitive deficits and A beta deposits in transgenic APP+PS1 mice. Neurobiology of Aging. 22(3):377-85. Morgan D. Diamond DM. Gottschall PE. Ugen KE. Dickey C. Hardy J. Duff K. Jantzen P. DiCarlo G. Wilcock D. Connor K. Hatcher J. Hope C. Gordon M. Arendash GW. 2000. A-beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408(6815):982-5. 2023-current: Huntington Study Group (HSG) Education Committee 2023-current: Huntington Study Group (HSG) Credentialing Committee 2021-current: American Academy of Neurology Medical Economics and Practice (MEP) Telehealth Subcommittee 2019-current: Huntington Study Group (HSG) Family Day Planning Committee 2017-current: International Parkinson’s Disease and Movement Disorders Society Telemedicine Work Group 2020-2021: Children Neurology Foundation Telehealth Initiative 2020-2021: American Academy of Neurology Innovation in Practice Work Group 2020-2021: American Academy of Neurology Teleneurology Education Curriculum for Residents Workgroup 2019-2021: Cerner Neurology Physician Advisor Council 2019-2021: American Academy of Neurology Practice Management and Technology Subcommittee 2020: American Academy of Neurology Telemedicine Reimbursement Work Group 2020: American Academy of Neurology Emergency Telemedicine Work Group 2017-2020: American Academy of Neurology Innovation Hub Working Group 2015-2019: American Academy of Neurology Telemedicine Working Group (Co-Chair) Current directory role is Movement Disorders Neurologist.

Victoria Shada — Synapticure publishes the following professional biography and affiliation: Born and raised in Indiana, Dr. Shada is a geriatric medicine specialist with a focus on primary care, memory and cognitive assessment, and dementia care, and is actively involved in research on cognitive health. Carolinas Medical Center (Internal Medicine) Wake Forest Baptist Medical Center (Geriatric Medicine) Creighton University School of Medicine Atrium Health Wake Forest Baptist I was born and raised in a small town in Indiana. Blessed with the unwavering support of my parents, the unchecked adoration of my grandparents, and the temporizing tough love of an older brother, I had all the elements I needed to achieve my dream of becoming a doctor. My training has taken me from Indiana to Nebraska, and from there to Arizona and North Carolina, where I currently live. I received my medical degree from Creighton University School of Medicine, completed my internal medicine residency at Carolinas Medicinal Center, and performed my fellowship in geriatric medicine at Wake Forest Baptist Health. I currently specialize in geriatric medicine, with expertise in primary care, long-term nursing home care, and memory/cognitive assessments, with a particular passion and focus on dementia care. I am engaged in multiple different research studies involving cognitive health and dementia care. In addition to being a physician, I am a devoted mother ( 1 human and 2 fur babies) and avid reader. Atrium Health Wake Forest Baptist Current directory role is Geriatrician.

Erin Leahy — Synapticure publishes the following professional biography and affiliation: Dr. Leahy is a board-certified geriatrician specializing in dementia and the complex medical needs that often come with aging. She takes a compassionate, patient-centered approach to care and works closely with individuals and their caregivers to support what matters most. University of Wisconsin Hospital and Clinics (Internal Medicine) Vanderbilt University (Geriatrics) Medical School: Medical College of Wisconsin (Doctor of Medicine) Postbaccealuareate: University of Wisconsin - Madison Undergraduate: New York University (BS Mathematics and Finance) American Geriatrics Society American Association of Geriatric Psychiatry Dr. Leahy was born and raised in Wisconsin. She attended New York University and worked in finance and consulting before earning her medical degree from the Medical College of Wisconsin. She completed her Internal Medicine residency at the University of Wisconsin and worked in hospital medicine before pursuing a Geriatrics fellowship at Vanderbilt University. She is board certified in both Internal Medicine and Geriatric Medicine. She has practiced Geriatrics since 2015 in a variety of care settings, including outpatient primary care at a PACE (Program of All-Inclusive Care for the Elderly) clinic, as medical director of an ACE (Acute Care of the Elderly) unit in an academic hospital, and most recently as a cognitive assessment specialist in consultative practice. She is committed to helping people age with grace and values a holistic, collaborative approach to care - always guided by what matters most to patients and their caregivers. Dr. Leahy currently lives in Milwaukee, WI, with her partner. In her spare time, she loves live music, good food, traveling and going on self-curated adventures involving hiking, backpacking and biking. American Geriatrics Society American Association of Geriatric Psychiatry Current directory role is Geriatrician.

Brook Croke — Synapticure publishes the following professional biography and affiliation: Brook is a genetic counselor with 15 years of experience, specializing in neurodegenerative disorders, neurogenetics, and newborn screening initiatives. M.P.H. University of Illinois (2015) M.S. in Genetic Counseling, Northwestern University (2011) B.S. in Biochemistry, University of Illinois (2006) National Society of s CLINGEN ALS Spectrum Disorders Gene Curation Expert Panel Brook has counseled hundreds of individuals and families regarding genetic testing options for the past 15 years. She has a passion for helping families living with neurodegenerative disorders. Prior to joining Synapticure in 2022, she worked as a genetic counselor at SIU Medicine, with a focus on neurogenetics and cardiomyopathies. She also has experience working in several genetic testing laboratories and worked with the Illinois Department of Public Health Newborn Screening Program to implement screening for lysosomal storage disorders. She resides in Springfield, Illinois with her husband and four children. ‍ https://www.synapticure.com/author/brook-croke https://pubmed.ncbi.nlm.nih.gov/23881473/ National Society of Genetic Counselors CLINGEN ALS Spectrum Disorders Gene Curation Expert Panel Current directory role is Genetic Counselor.

Krista Savage — Synapticure publishes the following professional biography and affiliation: Krista is a genetic counselor with 10 years of experience in neurogenetics, working with conditions like ALS, dementia, and Parkinson’s disease. Based in Salt Lake City, she enjoys hiking, skiing, and exploring national parks. University of Cincinnati (Genetic Counseling Graduate Program) Marquette University (Undergraduate) National Society of s Association for Utah Genetic Counselors Krista is a genetic counselor with ten years of clinical experience in neurogenetics. She has worked with many individuals and families with ALS, dementia, Parkinson’s disease, and other neurodegenerative conditions. Her experience includes working as a clinical and research genetic counselor in an academic medical center and providing telehealth genetic counseling services across multiple platforms. She received her M.S. degree in Genetic Counseling from the University of Cincinnati in 2014. Krista grew up in Wisconsin and enjoys spending time with animals and in the outdoors. She currently lives in Salt Lake City, Utah and enjoys hiking, skiing, and visiting national parks. Youmans and Winn Neurological Surgery E-Book: 4-Volume Set, HR Winn, Elsevier Health Sciences ‍ 5p deletions: Current knowledge and future directions, Joanne M Nguyen, Krista J Qualmann , Rebecca Okashah, Amysue Reilly, Mikhail F Alexeyev, Dennis J Campbell Familial syndromes involving meningiomas provide mechanistic insight into sporadic disease, K Kerr, K Qualmann , Y Esquenazi, J Hagan, DH Kim THSD1 (Thrombospondin Type 1 Domain Containing Protein 1) Mutation in the Pathogenesis of Intracranial Aneurysm and Subarachnoid Hemorrhage, Teresa Santiago-Sim, Xiaoqian Fang, Morgan L Hennessy, Stephen V Nalbach, Steven R DePalma, Ming Sum Lee, Steven C Greenway, Barbara McDonough, Georgene W Hergenroeder, Kyla J Patek, Sarah M Colosimo, Krista J Qualmann , John P Hagan, Dianna M Milewicz, Calum A MacRae, Susan M Dymecki, Christine E Seidman, JG Seidman, Dong H Kim Family history of cluster headache: a systematic review, MW Waung, A Taylor, KJ Qualmann , MJ Burish Behavioral assessment of acute inhibition of system x c - in rats, Victoria Lutgen, Jon Resch, Krista Qualmann , Nicholas J Raddatz, Cristina Panhans, Ellen M Olander, Linghai Kong, SuJean Choi, John R Mantsch, David A Baker Synthesis of chiral GABAA receptor subtype selective ligands as potential agents to treat schizophrenia as well as depression, Guanguan Li, Michael R Stephen, Revathi Kodali, Nicolas M Zahn, Michael M Poe, VVN Phani Babu Tiruveedhula, Alec T Huber, Melissa K Schussman, Krista Qualmann , Cristina M Panhans, Nicholas J Raddatz, David A Baker, Thomas D Prevot, Mounira Banasr, Etienne Sibille, Leggy A Arnold, James M Cook Pediatric epilepsy surgery: the prognostic value of central nervous system comorbidities in patients and their families, Krista J Qualmann , Christine G Spaeth, Melanie F Myers, Paul S Horn, Katherine Holland, Francesco T Mangano, Hansel M Greiner Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system x c − activity in the medial prefrontal cortex, V Lutgen, K Qualmann , J Resch, L Kong, SJ Choi, DA Baker Lynch Syndrome With Germline MSH2 Mutation in a Patient With Primary Anaplastic Glioneuronal Tumor, S Azam, LY Ballester, SH Ramkissoon, S Hsu, JJ Zhu, KJ Qualmann Genetic counselor approaches to BRCA1/2 direct‐to‐consumer genetic testing results, S Burke, M Mork, K Qualmann , A Woodson, M Jin Ha, B Arun, M Kaulfus Germline and somatic mutations in the pathology of pineal cyst: A whole‐exome sequencing study of 93 individuals, Yuanqing Yan, Rebecca Martinez, Maria N Rasheed, Joshua Cahal, Zhen Xu, Yanning Rui, Krista J Qualmann , John P Hagan, Dong H Kim Investigating Medical Examiners' Practices: Genetic Evaluation for Fatal Acute Aortic Dissection, B Power GENE-04. CHARACTERISTICS OF PATIENTS WITH A PRIMARY BRAIN TUMOR UNDERGOING HEREDITARY CANCER MULTI-GENE PANEL TESTING, Sarah Azam, Krista Qualmann , Syed Hashmi, Aarti Ramdaney, David Rodriguez-Buritica, Leslie Dunnington, Michelle Jackson 頭蓋内動脈瘤およびくも膜下出血の病態形成における THSD1 (Thrombospondin Type 1 Domain Containing Protein 1) の変異, Teresa Santiago-Sim, Xiaoqian Fang, Morgan L Hennessy, Stephen V Nalbach, Steven R DePalma, Ming Sum Lee, Steven C Greenway, Barbara McDonough, Georgene W Hergenroeder, Kyla J Patek, Sarah M Colosimo, Krista J Qualmann , John P Hagan, Dianna M Milewicz, Calum A MacRae, Susan M Dymecki, Christine E Seidman, JG Seidman, Dong H Kim NGTS-04SUGGESTION OF TP53 GERMLINE GENETIC TESTING BASED ON RESULTS FROM NEXT GENERATION SEQUENCING OF TUMOR SPECIMEN: A CASE REPORT, KJ Qualmann , DH Kim, S Papasozomenos, JJ Zhu NGTS-03CHARACTERIZATION OF PRIMARY GLIOMAS IN INDIVIDUALS WITH LI-FRAUMENI SYNDROME: A CASE SERIES, Krista J Qualmann , Nitin Tandon, Dong H Kim, Scott R Shepard, Meenakshi Bhattacharjee, Sozos Papasozomenos, Angel I Blanco, Jay-Jiguang Zhu Examining the Pediatric Epilepsy Surgery Population: The Prognostic Value of Central Nervous System Comorbidities in Probands and their Families, KJ Qualmann National Society of Genetic Counselors Association for Utah Genetic Counselors Current directory role is Genetic Counselor.

Pritika Patel — Synapticure publishes the following professional biography and affiliation: Pritika brings nine years of experience caring for older adults, with a background in cognitive neurology, movement disorders, and palliative care. She takes a collaborative approach that centers patients and their families. Pritika joins Synapticure with extensive experience acquired over nine years in various roles dedicated to the care of elderly patients. As a Registered Nurse in a memory care unit and adult day health program, she gained firsthand insight into the daily lives of those with cognitive impairments as well as the impact on their families. Transitioning to a Nurse Practitioner role in neurology, she specialized in cognitive impairments and movement disorders. In this capacity, she contributed to the organization and implementation of two new multidisciplinary clinics along with several research studies and publications, with the goal of enhancing patient care. Most recently, she served as a palliative care Nurse Practitioner, focusing on symptom management and goals-of-care discussions for patients with chronic illnesses in their homes. Her clinical practice is characterized by a collaborative approach with the patient and their support system, which includes loved ones, clinicians, and caregivers. She is committed to empowering patients and their families to advocate for their health and wellness. Originally from Massachusetts, where she currently resides, Pritika enjoys traveling and is working toward her goal of visiting all 50 US states (29 so far!). Current directory role is Cognitive Nurse Practitioner.

Christian Schenk — Synapticure publishes the following professional biography and affiliation: Dr. Schenk is a board-certified Behavioral Neurologist with over 13 years of experience in clinical care and research trials. His work focuses on advancing cognitive neurology through the development of innovative diagnostic and treatment modalities for dementia. University of Puerto Rico - Medical Sciences Campus University Hospitals - Case Medical Center, Cleveland University of Puerto Rico - School of Medicine Hospital UPR Dr. Federico Trilla University District Hospital San Juan University of Puerto Rico - Medical Sciences Campus Dr. Schenk is a Behavioral Neurologist with over 13 years of experience in clinical neurology care and clinical trials. He holds specialized training and certification in behavioral neurology. His research interests focus on cognitive neurology and dementia, with interest in exploring new diagnostic and treatment modalities for neurological disorders. Hospital UPR Dr. Federico Trilla University District Hospital San Juan University of Puerto Rico - Medical Sciences Campus Current directory role is Cognitive Neurologist.

Jeremy Pruzin — Synapticure publishes the following professional biography and affiliation: Dr. is a behavioral neurologist researching and treating Alzheimer’s and related dementias, with a focus on prevention through lifestyle and risk factor management. Rush University Medical Center Harvard Medical School Arizona State University (Masters in Healthcare Innovation) University of Santa Barbara California (BS in Biopsychology) University of Santa Barbara California (BA in Spanish) ‍ ‍ Dr. Pruzin is Board Certified in Neurology specializing in cognitive/behavioral neurology. He has been involved in Alzheimer’s disease research before starting medical school and continued this pursuit throughout his training. He spent three months in Medellin, Colombia during his final year of medical school interning for the Grupo de Neurociencias de Antioquia conducting research on the kindred affected by Autosomal Dominant Alzheimer’s Disease. He then completed his neurology residency at Rush University Medical Center. He investigated how diabetes influences the risk for Alzheimer’s disease, authoring original articles, a review, and a book chapter on the topic. Dr. Pruzin moved on to a fellowship at Harvard Medical School with additional clinical training at Brigham and Women’s Hospital. He was a sub-investigator on over ten clinical trials at the Center for Alzheimer's Research and Treatment during this period. He concurrently conducted observational research with the Harvard Aging Brain Study at Massachusetts General Hospital, focusing on the intersection of vascular risk factors, physical activity, and how their interactions with AD molecular pathology influence cognitive decline and dementia. He was awarded an Alzheimer’s Association Clinical Scientist Fellowship award to continue this work. Dr. Pruzin is an Associate Professor of Neurology at the University of Arizona College of Medicine and Banner Alzheimer’s Institute. His current research focus is modifiable risk factor interventions, especially in midlife, with the goal of reducing future risk of Alzheimer’s disease and related dementias by addressing risk factors like hypertension, diabetes, physical inactivity, and others earlier in life, when the impact of these interventions is likely to make the greatest difference in lowering future risk for dementia. ‍ Current directory role is Cognitive Neurologist.

Benjamin Williams — Synapticure publishes the following professional biography and affiliation: Dr. Benjamin J. Williams is a renowned neurologist, Alzheimer's researcher with 20+ years in clinical trials, and Adjunct Professor at Atrium Wake Forest with a deep-rooted history in Memory Disorders Clinics University of California San Diego School of Medicine Medical School - University of California San Diego School of Medicine Graduate - The University of Texas at Austin Undergraduate - The University of Texas at Austin 2018-2023: Atrium Wake Forest Baptist Health, active staff 2012-2017: Parkland Memorial Hospital, active staff 2012-2017: UT Southwestern Medical Center University Hospitals, associate staff 2004-2012: University Medical Center, Lubbock, TX, full staff 1997-2008: Covenant Health System, Lubbock, TX, full staff Benjamin J. Williams, MD, PhD is a graduate of the University of Texas Medical Branch at Galveston, Texas. He attended the University of Texas at Austin for both his undergraduate and graduate studies,  receiving both a Bachelor of Arts degree with high honors and a PhD in Zoology.  He Attended the University of Texas at Galveston where he received his MD and went on to complete a neurology residency at the University of California San Diego School of Medicine. Dr. Williams practiced general neurology and sleep medicine for many years at several practice locations in California, North Carolina, and Texas. He joined the neurology faculty at the Texas Tech School of Medicine and subsequently had neurology faculty appointments at the University of Texas Southwestern Medical School in Dallas, TX and at Atrium Wake Forest Baptist Health in Winston-Salem, NC. At these institutions Dr. Williams’ clinical efforts were primarily in the outpatient Memory Disorders Clinics. Dr. Williams has been involved in clinical trial work for over 20 years. Most of this work has been in the field of therapeutic trials for Alzheimer disease, and he remains currently active in Alzheimer disease research in his current position as an Adjunct Professor at Atrium Wake Forest Baptist Health. His research has included the use of monoclonal antibody therapies such as lecanemab, which is now FDA approved, in the treatment of Alzheimer disease. Dr. Williams is still an active member of the Wake Forest Alzheimer Disease Research Center, which has ongoing grant funding from the National Institutes of Aging. Williams BJ, Larimer JL & Gordan WH (1977). Production of localized lesions in the nervous system using silver nitrate. Comp. Biochem. Physiol., 57: 37-40. Garlick RL, Williams BJ & Riggs AF (1979). The hemoglobins of Phoronopsis viridis , of the primitive invertebrate phylum Phoronida: characterization and subunit structure. Arch. Biochem.Biophys., 194: 13-23. Williams BJ & Larimer JL (1980). Abdominal extension-evoking interneurons in crayfish: characteristics of the ganglionic driving networks. J. Exp. Zool., 214: 189-197. Williams BJ & Larimer JL (1981). Neural pathways of reflex-evoked behaviors and command systems in the abdomen of the crayfish. J. Comp. Physiol., 143:27-42. Williams BJ, Droge MH, Hester K & Leonard RB (1981). Induction of swimming in the high spinal stingray by L-DOPA. Brain Res, 220:208-13. Williams BJ, Livingston CA & Leonard RB. (1984). Spinal cord pathways involved in initiation of swimming in the stingray, Dasyatis sabina : spinal cord stimulation and lesions. J. Neurophysiol, 51:578-91. Ritchie TC, Roos LJ, Williams BJ, & Leonard RB (1984). The descending and intrinsic serotonergic innervation of an elasmobranch spinal cord. J. Comp. Neurol, 224:395-406. Williams BJ, Droge ME & Leonard RB (1988). Intracellular recording from pectoral fin motorneurons in the stingray, Dasyatis sabina , an elasmobranch fish. J. Neurophysiol, 51:666-79. Clark WM, Williams B, Selzer KA, Zweifler RM, Sabounjian Gammans RE (1999). A randomized efficacy trial of citicoline in acute ischemic stroke. Stroke, 30:2592-97. Warren MW, Hynan LS, Weiner MF, Doody R, Roundtree S, Capriles V, O’Bryant SE, Williams BJ, et al (2012). Lipids and adipokines as risk factors for Alzheimer’s disease. Journal of Alzheimer’s Disease , 29 , 1, 151-157. O’Bryant SE, Johnson LA, Balldin V, Edwards M, Barber RC, Williams BJ, Devous M, Cushings B, Knebl J, & Hall J (2012). Characterization of Mexican Americans with Mild Cognitive Impairment and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 33(2), 373-9. PMID: 22976076 Szerlip, HM, Edwards ML, Williams BJ, Johnson LA, Vintimilla RM & O’Bryant SE.  (2015). Association of cognitive impairment with chronic kidney disease in Mexican Americans. Journal of the American Geriatric Society 63(10), 2023-2028. Edwards M, Hall J, Williams B, Johnson L & O'Bryant SE (2016). Molecular markers of amnestic mild cognitive impairment among Mexican Americans. Journal of Alzheimer’s Disease 49, 221-228. Lockhart SN, Schaich CL, Craft S, Sachs B, Rapp SR, Jung Y, Whitlow C, Sai KKS, Cleveland MJ, Williams BJ, Burke G, Bertoni A, Hayden KM, Hughes TM. Associations among vascular risk factors, neuroimaging biomarkers, and cognition: Preliminary analyses from the Multi-Ethnic Study of Atherosclerosis (MESA). Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 05 September 2021 Tugce Duran, James R Bateman, MD, MPH; Benjamin J Williams, MD, PhD; Mark A Espeland, PhD; Timothy M Hughes, PhD; Stephanie Okonmah-Obazee, MS; Melissa M Rundle, PhD; Suzanne Craft, PhD; Samuel N Lockhart (December 2021). Neuroimaging and clinical characteristics of cognitive migration in community-dwelling older adults. Alzheimer’s & Dementia, Vol 17, Issue S1, e056241 Samuel N. Lockhart, Tim M. Hughes , Cynthia Suerken , Youngkyoo Jung , Christopher T. Whitlow , James R. Bateman , Benjamin J. Williams , Mark A. Espeland , Bonnie C. Sachs , Kathleen M. Hayden, Laura D. Baker , Suzanne Craft (December 2021). Cardiometabolic disorders are associated with reduced cerebral perfusion and white matter microstructure. Alzheimer’s & Dementia, Vol 17, Issue S1, e055791 Claudia Coffin, Cynthia K. Suerken, James R. Bateman, Christopher T. Whitlow, Benjamin J. Williams, Mark A. Espeland, Bonnie C. Sachs, Maryjo Cleveland, Mia Yang, Samantha Rogers, Kathleen M. Hayden, Laura D. Baker, Jeff Williamson, Suzanne Craft, Timothy M. Hughes, Samuel N. Lockhart. (July 2022). Vascular and microstructural markers of cognitive pathology. Alzheimer’s Dement.2022;14:e12332 2018-2023: Atrium Wake Forest Baptist Health, active staff 2012-2017: Parkland Memorial Hospital, active staff 2012-2017: UT Southwestern Medical Center University Hospitals, associate staff 2004-2012: University Medical Center, Lubbock, TX, full staff 1997-2008: Covenant Health System, Lubbock, TX, full staff 1994-1997: Forsyth Memorial Hospital, Winston-Salem, NC, full staff 1994: Craven Regional Medical Center, New Bern, NC, full staff 1991-1993: French Hospital Medical Center, San Luis Obispo, CA, full staff 1991-1993: Sierra Vista Regional Medical Center, San Luis Obispo, CA, full staff Current directory role is Cognitive Neurologist.

Lyndsay Mentgen — Synapticure publishes the following professional biography and affiliation: Lyndsay has more than a decade of experience in cognitive neurology and is passionate about providing comprehensive dementia care for patients and their families. Lyndsay is an with more than a decade of experience in cognitive neurology. She is passionate about providing comprehensive dementia care that addresses medical, behavioral and caregiving implications for patients and their families. Current directory role is Advanced Practice Registered Nurse.

Terri Long is listed in Synapticure’s current public Patient & Caregiving Advisors directory. This is a source-qualified advisory affiliation rather than clinical employment or evidence of a personal investment.

Penelope Cox is listed in Synapticure’s current public Patient & Caregiving Advisors directory. This is a source-qualified advisory affiliation rather than clinical employment or evidence of a personal investment.

Patti Stevens is listed in Synapticure’s current public Patient & Caregiving Advisors directory. This is a source-qualified advisory affiliation rather than clinical employment or evidence of a personal investment.

Mary Stevens is listed in Synapticure’s current public Patient & Caregiving Advisors directory. This is a source-qualified advisory affiliation rather than clinical employment or evidence of a personal investment.

Jim Contreras is listed in Synapticure’s current public Patient & Caregiving Advisors directory. This is a source-qualified advisory affiliation rather than clinical employment or evidence of a personal investment.

Hope Maruzo is listed in Synapticure’s current public Patient & Caregiving Advisors directory. This is a source-qualified advisory affiliation rather than clinical employment or evidence of a personal investment.

Heather Walker is listed in Synapticure’s current public Patient & Caregiving Advisors directory. This is a source-qualified advisory affiliation rather than clinical employment or evidence of a personal investment.

Gerry Shultz is listed in Synapticure’s current public Patient & Caregiving Advisors directory. This is a source-qualified advisory affiliation rather than clinical employment or evidence of a personal investment.

Amy Armstrong is listed in Synapticure’s current public Patient & Caregiving Advisors directory. This is a source-qualified advisory affiliation rather than clinical employment or evidence of a personal investment.

Alan Curtis is listed in Synapticure’s current public Patient & Caregiving Advisors directory. This is a source-qualified advisory affiliation rather than clinical employment or evidence of a personal investment.

Todd Park is listed among Synapticure’s scientific and strategic advisers. The issuer publishes the professional affiliation Co-Founder, Executive Chairman at Devoted Health. This outside title is retained as a source-qualified professional description rather than Synapticure operating employment. Additional career details and dates are not disclosed in this directory.

Shane A. Liddelow is listed among Synapticure’s scientific and strategic advisers. The issuer publishes the professional affiliation Associate Professor, Department of Neuroscience and Physiology and Associate Professor, Department of Ophthalmology. This outside title is retained as a source-qualified professional description rather than Synapticure operating employment. Additional career details and dates are not disclosed in this directory.

Sarah DeVos is listed among Synapticure’s scientific and strategic advisers. The issuer publishes the professional affiliation Senior Director, Drug Maker, Oligonucleotides, Curie.Bio. This outside title is retained as a source-qualified professional description rather than Synapticure operating employment. Additional career details and dates are not disclosed in this directory.

Nathan Bays is listed among Synapticure’s scientific and strategic advisers. The issuer publishes the professional affiliation Board of Directors, Unite US. This outside title is retained as a source-qualified professional description rather than Synapticure operating employment. Additional career details and dates are not disclosed in this directory. FINRA’s2026 public report for Nathaniel Martin BaysIII, CRD6778354, lists LifeForce Capital LLC as a healthcare venture-capital outside affiliation begun March25,2019, with the precise title Venture Advisor and approximately two hours monthly advising the founder. The same report identifies a Unite US board role begun April2020, providing an exact career bridge to Nathan Bays’ existing Synapticure adviser biography. This is a part-time advisory affiliation rather than a presumed full-time investment partner; the original named Synapticure portrait and all other roles are retained.

Jinsy Andrews — Synapticure publishes the following professional biography and affiliation: Dr. Andrews has over 15 years of experience caring for people with neuromuscular disorders, primarily Amyotrophic Lateral Sclerosis. In addition, she has extensive experience conducting and overseeing clinical trials in both the academic and industry setting and has held several leadership positions in organizations that focus on ALS clinical trials and care. Dr. Andrews received B.S. from Union College, M.Sc. in Biostatistics (Patient-Oriented Research) from Columbia University's Mailman School of Public Health, and M.D. from Albany Medical College. Dr. Andrews completed her residency in Neurology at the University of Connecticut and completed fellowship training in both Neuromuscular Medicine and Clinical Neurophysiology at Columbia University. Dr. Andrews is board certified in Neurology, Neuromuscular Disease, and Electrodiagnostic Medicine. ‍ The affiliation is scientific/strategic advice; outside employer and university titles remain external.

Glen Finney is listed among Synapticure’s scientific and strategic advisers. The issuer publishes the professional affiliation Director of Neurology, Geisinger and Member of the American Academy of Neurology. This outside title is retained as a source-qualified professional description rather than Synapticure operating employment. Additional career details and dates are not disclosed in this directory.

Gene Yeo is listed among Synapticure’s scientific and strategic advisers. The issuer publishes the professional affiliation Sanford Stem Cell Institute Endowed Chair Professor, Dept of Cellular and Molecular Medicine, University of California, San Diego. This outside title is retained as a source-qualified professional description rather than Synapticure operating employment. Additional career details and dates are not disclosed in this directory.

Evangelos Kiskinis is listed among Synapticure’s scientific and strategic advisers. The issuer publishes the professional affiliation Assistant Professor of Neurology and Neuroscience, New York Stem Cell Foundation, Robertson Investigator, Scientific Director Stem Cell Core Facility. This outside title is retained as a source-qualified professional description rather than Synapticure operating employment. Additional career details and dates are not disclosed in this directory.

Eric Anderson — Synapticure publishes the following professional biography and affiliation: Dr. Anderson is passionate about leveraging technology to develop novel specialty practice models focused on creating the greatest value, outcomes, and experiences for patients. He is recognized as a national leader in telemedicine, mobile health, and alternative practice models. He trailblazed the use of mobile telemedicine in emergency neurology and was the first to demonstrate and publish that remote stroke assessment could be performed with an iPhone. He speaks nationally on the topics of telemedicine, mobile health, and practical applications of technology in the enhancement of patient care. He joined Synapticure from SOC Telemed where He had previously served as the Director of Scientific Affairs, National EEG Director, and Chair of Neurology, where he developed and managed the largest teleneurology practice group, seeing a volume of 8500 consults per month across 300 hospitals. Dr Anderson has led multiple efforts to support and define the practice of teleneurology with the American Academy of Neurology and other organizations. The affiliation is scientific/strategic advice; outside employer and university titles remain external.

Chris Hogg is listed among Synapticure’s scientific and strategic advisers. The issuer publishes the professional affiliation Life Sciences Advisor. This outside title is retained as a source-qualified professional description rather than Synapticure operating employment. Additional career details and dates are not disclosed in this directory.

Anton Arbatov is listed among Synapticure’s scientific and strategic advisers. The issuer publishes the professional affiliation Digital Health Expert, Adjunct Professor and Member of the Board of Advisors, College of Public Health, George Mason University. This outside title is retained as a source-qualified professional description rather than Synapticure operating employment. Additional career details and dates are not disclosed in this directory.

Amy DuRoss is listed among Synapticure’s scientific and strategic advisers. The issuer publishes the professional affiliation Advisor. This outside title is retained as a source-qualified professional description rather than Synapticure operating employment. Additional career details and dates are not disclosed in this directory.

Adam Schlifke is listed among Synapticure’s scientific and strategic advisers. The issuer publishes the professional affiliation Stanford Anesthesia Digital Health Lead. This outside title is retained as a source-qualified professional description rather than Synapticure operating employment. Additional career details and dates are not disclosed in this directory.

Aaron Gitler — Synapticure publishes the following professional biography and affiliation: Aaron Gitler is the Stanford Medicine Basic Science Professor in the Department of Genetics at Stanford University. He received his B.S. degree from Penn State University and did his PhD studies on cardiovascular development in the laboratory of Dr. Jonathan Epstein at the University of Pennsylvania. Then he performed his postdoctoral training with Dr. Susan Lindquist at the Whitehead Institute for Biomedical Research and MIT. In 2007, he established his laboratory at the University of Pennsylvania and moved to Stanford in 2012. His laboratory has been using a combination of yeast and human genetics approaches to investigate pathogenic mechanisms of ALS. He and his colleagues discovered mutations in the ATAXIN2 gene as a genetic contributor to ALS and has identified several therapeutic targets for ALS. He is a scientific co-founder of Maze Therapeutics The affiliation is scientific/strategic advice; outside employer and university titles remain external.

Oleg Yerstein — Synapticure publishes the following professional biography and affiliation: Dr. Yerstein joins us from Beth Israel Lahey Health, where for five years he served as Director of the Center for Memory and Cognitive Disorders. In that role, he helped implement both clinical and research use of the latest dementia biomarkers, founded the anti-amyloid therapies clinic, and led numerous clinical trials for Alzheimer’s disease and other neurodegenerative disorders. Oleg brings extensive experience building collaborations across clinical care programs, academic centers, trial sites, and the healthcare industry to expand access to the latest therapies and accelerate the development of interventions that improve patient outcomes. Current directory role is Director of Cognitive Care Service Line, Neurologist.

Noreen Flanagan — Synapticure publishes the following professional biography and affiliation: For over two decades Dr. Flanagan has been caring for people with neurodegenerative diseases. Her professional career began in Boston as a Physical Therapist for people with movement disorders and other neurological conditions. Her second career, as a physician, began in Maine where she developed a regional interdisciplinary Memory Clinic for patients with cognitive decline. Concurrently, Dr. Flanagan also developed an interdisciplinary tele-psychiatry program for patients with neurodegenerative disease living in assisted living and long term care homes. Access to comprehensive compassionate care for all patients, regardless of their location, was the driving force behind Dr. Flanagan’s development of these programs, and the reason she chose to continue her career at Synapticure. She appreciates the team approach to each individual’s care at Synapticure, and the inclusion of loved ones in the process. ‍ Current directory role is Director of Behavioral Health, Psychiatrist.

Melissa Yu — Synapticure publishes the following professional biography and affiliation: Melissa Yu, MD, FAAN is a board-certified neurologist and Fellow of the American Academy of Neurology with extensive expertise in neurodegenerative diseases and brain health. She is a graduate of the Mount Sinai School of Medicine and completed her neurology training at Baylor College of Medicine. Prior to joining Synapticure, Dr. Yu served on the faculty at Baylor College of Medicine for more than a decade, advancing through the academic ranks to Professor of Neurology. During her tenure, she also served as a Physician Informaticist, as Director of the Alzheimer’s Disease and Memory Disorders Center, and was the site Principal Investigator for numerous clinical trials, including the landmark U.S. POINTER study. In addition, Dr. Yu has held multiple leadership positions within the American Academy of Neurology, contributing to national initiatives in clinical care, education, and research. Dr. Yu is deeply dedicated to helping patients and their families navigate the complexities of neurodegenerative diseases with clarity, compassion, and evidence-based care. Current directory role is VP, Clinical Operations.

Elizabeth Ferluga — Synapticure publishes the following professional biography and affiliation: Dr. Ferluga was born in Kennewick, WA.  She completed her undergraduate degrees in psychology and neuroscience in 2003 at Washington State University.  She went on to University of Iowa Carver College of Medicine.  She graduated with AOA honors in 2007.  She completed her residency in Neurology at Vanderbilt in Nashville, TN. She served as neurology chief resident in 2011.  She subsequently went on to be a general neurology attending and movement disorder fellow, graduating in 2013.  She then joined faculty at Vanderbilt as an assistant professor practicing both general neurology and movement disorders.  She further participated development of a pediatric movement disorder clinic. In 2015, she moved to Chattanooga, TN.  She was hired at Erlanger medical center to develop a movement disorder program.  While working at Erlanger, she served as Clinic Director and Medical Director of the neurology service line.  She also served as the director of Erlanger’s HD center of excellence (partner with Vanderbilt since 2016). She left Erlanger medical center in 2023.  She is now practicing teleneurology with synapticure focusing on total care for patients with neurodegenerative diseases such as Parkinson’s disease and Huntington’s disease. Current directory role is Director of Movement Disorders.

Alex Muresan — Synapticure publishes the following professional biography and affiliation: Alex is an engineering and product leader who has built a career delivering patient- and provider-facing healthcare technology at scale, with a strong focus on reliability, security, and user experience. At Synapticure, he is excited to help build scalable engineering systems and high-quality product experiences that make care easier for patients, caregivers, and clinicians, and to support a culture that values collaboration, clarity, and outcomes. Prior to joining Synapticure, Alex scaled Foodsmart’s engineering and product teams as well as the platform from seed stage through Series D. In that work, he partnered closely with cross-functional leaders to translate business and clinical needs into technical strategy and execution, while strengthening the foundations that enable teams to move quickly and safely, including architecture, developer productivity, planning and delivery processes, and operational excellence. Earlier in his career, Alex was a full-stack developer and iOS app developer, which continues to shape his hands-on approach to building end-to-end products and mentoring teams. He brings a pragmatic leadership style that balances velocity with quality, and he is passionate about delivering great user experiences, especially in healthcare, where thoughtful design and dependable systems can have an outsized impact on real people. Current directory role is VP, Product & Engineering.

Mike Payne — Synapticure publishes the following professional biography and affiliation: At Synapticure, Mike is focused on expanding access to the most effective treatments for patients with serious neurological conditions, whether those medicines are already on the market or in pre-approval testing. This mission is deeply personal for him, driven by the fact that neurological diseases represent the largest and fastest-growing epidemic the U.S. will face over the next 50 years, and informed by his own experience losing his mother to complications from Alzheimer’s disease in 2021. Mike leads the company’s strategic engagements with pharmaceutical and biotechnology firms, as well as major CROs, enabling them to leverage Synapticure’s specialized capabilities. These services include clinical trial outsourcing and enablement for both observational and interventional studies, RWE/RWD data collection and analysis, lab services via advanced organoid models, Expanded Access Programs for pre-market drugs, and Direct-To-Patient (DTP) programs for marketed products. Alongside his colleagues, he oversees every aspect of these initiatives, from initial business development and sales to final delivery and patient outcomes. Current directory role is SVP, Life Sciences Business Development.

Kathleen Beach — Synapticure publishes the following professional biography and affiliation: Kathleen leads People Strategy at Synapticure. She is passionate about building scalable people systems that empower employees to do their best work. She specializes in embedding company values and empowering leaders to drive team performance through a positive and impactful culture. Her career began with a focus on scientific rigor in a CDC-funded HIV prevention trial, followed by strategic planning for organizations in the social sector. This unique blend of experience led her to discover a passion for HR, which she pursued by leading the people function at her consulting firm. She then went on to serve as Head of HR at a mission-driven technology startup. Prior to joining Synapticure, Kathleen spent nine years at Twist Bioscience, where she helped guide the company through a period of immense growth from 150 to over 1,000 employees and its IPO. As a leader in HR operations and analytics, she built comprehensive talent management programs, including performance frameworks, culture, and total rewards, that established the company as a leading biotech employer. Kathleen holds dual degrees in Biology and Music from UC San Diego and an MA from San Francisco State University. Current directory role is VP, People.

Suzie Sheetz — Synapticure publishes the following professional biography and affiliation: Suzie Sheetz is a seasoned healthcare executive with a track record of driving strategic growth and transformative partnerships. With deep expertise in go-to-market strategy and execution, she has helped early-stage companies scale by forging high-impact relationships across the provider and payer landscape. Before joining Synapticure, Suzie served as VP of Growth & Business Development at Cityblock Health, where she led value-based care initiatives and was responsible for health plan sales across Medicaid, Medicare, and dual-eligible business lines. She has also held commercial roles at digital healthcare startups, Ronin and Included Health, focusing on innovative healthcare solutions. Suzie is committed to improving healthcare access for vulnerable populations and ensuring sustainable access to care. She holds a BA from Northwestern University and an MPH from the Harvard School of Public Health. Current directory role is Head of Growth & Business Development.

Sam Magidsohn — Synapticure publishes the following professional biography and affiliation: Sam has built a career at the intersection of healthcare finance, strategic planning, and operational execution. Sam serves as the Head of Finance at Synapticure, leading financial strategy and driving value creation through innovative financial modeling, risk management, and business optimization. Prior to joining Synapticure, Sam grew his expertise in healthcare investing, and has a deep understanding of market dynamics, regulatory complexities, and the evolving landscape of healthcare innovation. Sam's experience spans across private investing, mergers & acquisitions, and startup finance, where he demonstrated the ability to identify high-growth opportunities, execute complex deals, and support companies in scaling for success. In addition to investment leadership, Sam has extensive experience in operational strategy, partnering with cross-functional teams to streamline processes, enhance financial performance, and foster sustainable growth. With a passion for creating strategic partnerships and driving operational efficiency, he works to bridge the gap between financial performance and healthcare outcomes. Sam holds a MBA from University of Chicago and a BBA from the University of Michigan. Current directory role is Chief Financial Officer.

Anay Patel — Synapticure publishes the following professional biography and affiliation: Specialty virtual care models make access possible for every patient—not just those who live close enough to receive care. Pairing this with comprehensive care coordination ultimately drives better outcomes for patients, their families, and the caregivers who support them. That belief drives Anay Patel, Synapticure's Chief Operating Officer, who brings unique experience at the intersection of healthcare operations, finance, and strategy, along with a track record of scaling and building growth-stage companies. Prior to joining Synapticure, Anay served as COO of QualDerm Partners, a national dermatology medical group and MSO, where he held full P&L accountability across a network of more than 250 clinics and 450 clinicians nationwide. Before that, he was President & COO of QuartetHealth, where he helped scale the business and its provider network through to a successful exit. Earlier in his career, Anay held leadership roles at MDInsider and Accolade, and began his career in healthcare management consulting and investment banking, advising health systems, payers, and medical groups on strategy and M&A. Anay holds an MBA from the University of Chicago's Booth School of Business, a Master's in Health Systems Management from Rush University, and a BS from Indiana University. Current directory role is Chief Operating Officer.

Jason Langheier — Synapticure publishes the following professional biography and affiliation: Jason Langheier, MD, MPH, is the CEO and Founder of Foodsmart – the leading provider of telenutrition and value-based foodcare -- making eating well simple and affordable for millions of Americans. Dr. Langheier did neuroscience, genetics and bioinformatics research at Williams, Duke, Cambridge and NIH, and received his MD from Duke, and his MPH from Harvard. Applying behavioral neuroscience and nutritional epidemiology training, he developed the pediatric obesity clinic at Boston Medical Center (Nutrition & Fitness for Life), Fitness Forward and the Coach K Drive 2 Fitness. He was the CTO and Co-Founder of Proventys (now US Oncology/ McKesson), collaborating with the National Comprehensive Cancer Network to deliver personalized cancer care decision support. He is an active member of the Partnership for a Healthier America (PHA) Board of Directors, and loves hiking, playing sports and music with family and friends. ‍ Current directory role is Co-Founder, Board Co-Chair.

Peter Wallach — Synapticure publishes the following professional biography and affiliation: Peter entered the healthcare space after Brian’s diagnosis, originally focusing on investing in targeted therapeutics that had the potential to be truly disease altering in ALS. With Synapticure, Peter hopes to resolve the lack of early intervention, access to quality care, holistic patient data and clear subgrouping of people living with ALS. These shortcomings of the current system have hindered the success of ALS trials broadly and made it difficult to bring forward drugs that focused on specific subsets of the ALS patient population and could better the lives of all people living with ALS. Prior to working to help solve ALS, Peter worked in the cleantech industry before becoming a consultant at Bain & Company in their Chicago office. Peter received his MBA from Columbia University and undergraduate degree from The University of Virginia. ‍ Current directory role is Co-Founder, Life Sciences.

Brian Wallach — Synapticure publishes the following professional biography and affiliation: Brian Wallach, ALS patient, Co-Founder and Board-Co-Chair of Synapticure, a specialty telehealth clinic transforming the experience & outcomes of neurodegenerative disease for patients and caregivers across the U.S. Brian was diagnosed with ALS in November 2017 and since then has become an outspoken, well-known and impactful patient advocate in the neurodegenerative disease space. In addition to co-founding the nonprofit I AM ALS, Brian was an Assistant United States Attorney in the Northern District of Illinois and Senior Vetting Counsel in the Obama White House. Brian received his BA from Yale University and his JD from the Georgetown University Law Center. Current directory role is Co-Founder, Board Co-Chair.

Sandra Abrevaya — Synapticure publishes the following professional biography and affiliation: Sandra Abrevaya is the Co-Founder and CEO of Synapticure, a leader in neurodegenerative virtual care. Synapticure provides transformational support for patients and caregivers through access to specialized neurologists, cutting-edge medical treatments and trials, and personalized, wraparound services. She is also the Co-Founder of I AM ALS, an advocacy organization she established with her husband, Brian Wallach, after his ALS diagnosis in 2017 at the age of 37.Before Brian's diagnosis, Sandra served as the founding CEO of a nonprofit organization and held senior roles in public service, including positions with the City of Chicago, the U.S. House of Representatives, the U.S. Senate, the U.S. Department of Education, and the White House.Sandra's journey is shaped by her dual role as a caregiver—to Brian and mom to their two spunky daughters, aged 7 and 9—and as an advocate. Their story is the subject of the documentary For Love and Life, which highlights their fight against ALS and their commitment to making a difference in the lives of others facing similar challenges. Current directory role is Co-Founder, Chief Executive Officer.

Yangyang Wang is one of three WearWorks co-founders named in Pratt’s May2018 primary account, alongside Kevin Yoo and Keith Kirkland. A2015 Master of Industrial Design alumnus, he worked on haptic-motor navigation concepts and the Wayband prototype. He is named as a co-inventor on US10371544B2. The current Haptic leadership roster does not name him; no present COO position, unrelated academic homonym or unverified portrait is adopted.

Frances West is the accessibility and partnerships adviser named in Haptic’s older unlinked team roster. Its former IBM chief accessibility officer description is explicitly historical. Her absence from the current linked adviser section leaves the present company affiliation unconfirmed; no current IBM job or personal financing is inferred.

Peter Chang is the lead UX/UI designer published on Haptic’s older unlinked roster, with apps and wearables design responsibilities. The named original company portrait supports this specific identity. He is absent from the current linked team roster, so current employment is unconfirmed; unrelated Chang or Peter identities are not merged.

Rehan Saleem is the senior iOS developer named in Haptic’s older unlinked roster, with iOS SDK and app/Apple Watch work. He is not named on the current linked leadership/advisory page. His genuine older company portrait and affiliation are retained with current status unconfirmed, rather than a presumed present executive position.

Stephen Sheetz is the senior Android developer named on Haptic’s older unlinked team roster, which assigns Android SDK work. He is absent from the currently linked team page; this is a source-aged published development affiliation, without an invented current employment term or departure date.

RJ Krawiec is the policy and strategy adviser published by Haptic. The site supplies an undated Deloitte chief-marketing-officer caption without specifying a presently verified global or regional mandate. This scoped advisory affiliation is distinct from a current outside employment claim, statutory company board appointment or investor ticket.

Ravi Kolli is the technology-strategy adviser named and pictured on Haptic’s linked team page. Its external Sr Pago CTO caption is undated context and does not independently prove a current outside appointment. The affiliation does not establish company equity ownership or an individually allocated check.

Shaun Stewart is Haptic’s published growth and strategy adviser. Its current linked page describes him as a former Waymo chief business officer. The appointment is a company advisory affiliation, without a presumed current Waymo job, statutory directorship, or personal financing check.

Matthieu Dederichs is a UK-based technology investor whose published Merantix remit includes software, AI, financial technology, healthcare technology and consumer businesses.

Rockman Law invests in early-stage European AI, enterprise software, financial technology and deep technology. He previously founded a cybersecurity company and invested as an angel.

Nicole Büttner is a founding partner of Merantix Capital and leads enterprise AI solutions business Merantix Momentum. Her background combines economics and entrepreneurship.

Adrian Locher co-founded Merantix and builds and invests in AI companies. His entrepreneurial background spans more than twenty companies.

Rasmus Rothe co-founded Merantix and invests in applied AI. He holds a doctorate in computer vision and deep learning and helped establish the German AI Association.

Enzo Caruso is the Head of Operations named and pictured on Haptic’s current linked leadership page. An older company roster also described operations and growth responsibilities. This role concerns the WearWorks/Haptic navigation and tactile-interface business; no unrelated Caruso identity or private investment is inferred.

Abha Nath is identified as Wonder Venture Partner on the firm’s official founder-LP community page, which also describes her Whatnot affiliation. Dustin Rosen’s November2018 announcement records her earlier joining as investment analyst. The venture-partner affiliation is explicitly distinct from the main five-person team directory and does not make the wider LP community staff.

Taylor Bolhack is Wonder Ventures’ advisor and former head of platform. Her prior work included Bird’s market expansion, Square sales and Citibank recruitment and project management. She studied organisational development and corporate strategy at Vanderbilt.

Lida Vandermeer heads platform at Wonder Ventures. Her operating background includes Box, Apple and early-stage AI and crypto businesses. She supports founders, community and growth. Her education included Dartmouth and UC Berkeley, earning a cognitive-science degree.

Jiyoung Jeong is a senior associate investor at Wonder Ventures. Her background includes Wellspring Consulting, Primary Venture Partners’ Factor Fellowship, entrepreneurship and Fulbright teaching in Taiwan. She studied history at Stanford, graduating with honours and Phi Beta Kappa.

Valentina Rodriguez is a general partner at Wonder Ventures. Earlier Morgan Stanley work spanned credit analytics, trading and Latin American equity research. She studied industrial and labour relations at Cornell. Her promotion is corroborated by the founder’s recent announcement.

Dustin Rosen founded Wonder Ventures after building and selling consumer-technology startup Pose. His earlier investing career included the Mailroom Fund, following work at William Morris Agency. He studied economics at Wharton and leads Wonder as managing partner.

Atish Banerjea joined The Biological Computing Co. inSeptember2026 as strategic adviser for real-time inference and biological compute. His published company biography describes previously serving as Meta CIO after joiningFacebook in2016, NBCUniversal executive vice president and CIO, and earlier technology leadership at DexOne and Pearson. His advisory remit covers systems architecture, infrastructure strategy, organizational design, technical milestones and strategic partnerships. The advisory appointment is not classified as ordinary company employment or an investment, and no unverified portrait is substituted.

Keith Kirkland is the Haptic/WearWorks co-founder and current Chief Haptics Officer. His TED biography describes mechanical-engineering, industrial-design and accessories-design training. Pratt identifies him as a2015 industrial-design master’s alumnus. NSF names him principal investigator on wearable haptic-navigation award1746671, separately from any personal venture investment.

Janice Fong Hansen is Office Manager at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Bayer. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Kevin H Yoo is the Haptic/WearWorks co-founder and CEO named on the current linked leadership page. Pratt identifies Kevin Yoo among its2015 Master of Industrial Design alumni who co-founded WearWorks and developed accessible tactile navigation. He works on communicating information through vibration and product design; the company’s precise2017 demonstration involved15miles of the New York City Marathon.

Aleks Keser is Lead Recruiter at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Plenty, Coinbase, Intuit. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Sandeep Ankin is Product and Sales Engineer at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Satsyil. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Liz Cahill is Operations Manager, EA at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Maryland Neurosurgery. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Marissa Muller is VP of Communications at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Tesla. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Vik Chaudhary is VP of Products & Partnerships at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Meta, Dropbox, Oracle, MIT. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Katie Greenfield is VP of Finance and Operations
 at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Culture, Solugen. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Doyin Olaoye is AI Performance Engineer at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: AWS. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Harsha Musunuri is Senior AI Researcher at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Dolby. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Jason Ngo is AI Researcher at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: United Health Group. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Filip Marić, PhD is Senior AI Researcher at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Meta. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Mansour Abtahi is Senior AI Researcher at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: UCSF . The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Cheng-Yang Fu is Staff AI Researcher at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Meta. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Xudong Ma is Staff AI Researcher at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Causal, Meta, Apple. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Yuan Yen Tai is Staff AI Researcher at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Apple, Amazon. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Tai-peng Tian is Head of Computer Vision at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Meta, Apple. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Brian Mullen is Computational Neuroscientist at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: University California, Santa Cruz . The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Patrick Honma, PhD is Computational Neuroscientist at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Gladstone Institutes . The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Michael Silvernagel is Computational Neuroscientist at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Stanford. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Harsha Sanamandra’s own professional profile identifies EigenH affiliation in the Austin metropolitan area and describes a healthcare product-management focus on AI-powered products. BaladityaSaiChinni’s first-hand EigenH voice-workflow announcement names Harsha among colleagues building the platform alongside founder DheerajInampudi. These primary disclosures support a scoped public product-team affiliation; no CEO,cofounder,board or engineering executive title, exact appointment day or unrelated namesake career is assumed.

Lawson Fuller is Computational Neuroscientist at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Imagia, UCSD. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Bheema Subramanyeswar Reddy Tatiparthi announces starting as a cloud engineer at EigenH, thanking founder DheerajInampudi. His own professional biography describes full-stack development and associate cloud-engineering work on reliable cloud infrastructure, automation,CI/CD,AWS andGCP. His profile lists RGUKT Ongole education during2022–2026 and software projects, while a named EigenH colleague corroborates his team affiliation. Exact appointment day and a fuller unpublished executive rank are not inferred.

Baladitya Sai Chinni is an EigenH AI engineering-team member who describes his work on the platform’s healthcare voice workflow in a first-hand product-launch post. His engineering includes grounding agent responses in actual scheduling-tool results, confirming bookings before writes, defined escalation paths, low-latency conversational performance and configuration-driven practice setups. His own professional biography identifies AI automation and agentic-workflow experience, including RAG and LLM projects. His original individually named post portrait is genuine and visually inspected. An exact formal company rank and appointment day are unpublished.

Haggai Agmon is Computational Neuroscientist at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Stanford. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Shaik Mahammad Jani announces in his own professional post that he joined EigenH AI as a founding engineer at its V1 launch. He describes contributing across the full stack to healthcare AI products that simplify administrative workflows. His published technical background includes React,Node,Express,Django and AWS serverless; BaladityaSaiChinni independently names him among the team engineering the practice-controlled voice and scheduling product. Exact appointment day, equity ownership and clinical credentials are not established in reviewed sources.

Han de Jong is Senior Computational Neuroscientist at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: University California, Berkeley . The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Karthik Rommula identifies himself as EigenH AI founding AI engineer in his own professional launch post. He describes developing an agent-first healthcare SaaS product with DheerajInampudi to address missed calls, no-shows and manual front-desk work in smaller healthcare organisations. His own profile also describes agent grounding and software systems work, including the Saidso grounding-firewall project. He graduated from KG Reddy College of Engineering and Technology, where he previously served as AIClub vice-president and later returned as a workshop speaker. Exact company appointment day is unpublished; founding engineer does not establish a separate personal equity check.

Steven Jerjian, PhD is Neuroscientist at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Johns Hopkins, UCL Queen Square. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

William Barnes, PhD is VP of Technology at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Max Planck Society. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

John Wittig, PhD is VP of Engineering at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: iBoss, NIH. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Sasha Nikolaeva is Biology Research Associate at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Turku Bioscience . The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Dominique Cajanding is Biology Research Scientist at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Sonoma Bio. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Simone Chiola is Biological Scientist at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Stanford. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Marisol Cortes, PhD is Biological Scientist at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: Johns Hopkins. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Cristina Florio is Director of Biology, Baltimore at The Biological Computing Co. (TBC), according to its current public team directory. The same primary biography card identifies previous experience: NIH. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Jon Pomeraniec is COO & Co-Founder at The Biological Computing Co. (TBC), according to its current public team directory. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Alex Ksendzovsky is CEO & Co-Founder at The Biological Computing Co. (TBC), according to its current public team directory. The affiliation belongs to its biological-neural computing and AI research company, not an unrelated similarly named organisation.

Sarah Pennebaker, CIPM, confirms a continuing 111° West Capital affiliation in her own professional statement announcing Outlier CFO with Oscar Ku. She describes strategic CFO support for venture firms and growing companies. Her own profile documents prior Aduro Advisors work, Texas Christian University attendance and CIPM certification. Secondary directories describe a senior director of finance title, but the retrieved primary statement does not independently confirm it. The manager role records the verified affiliation without that title or guessed employment dates. Her authentic portrait was not retrievable.

Daniel Tully, also publicly referred to as Dan Tully, is a 111° West Capital investment-team affiliate identified by his own current professional profile and investment commentary. His public statements discuss institutional backing of Healia, Arine and Cherry; these statements do not establish personal contributions. Secondary directories describe a principal title and earlier healthcare investment banking, but the retrieved primary profile hides the employment details. Those titles and education are therefore not asserted here. He is distinct from existing David, Michael, Mike and Tim Tully records.

Andrew Brooks is a physician investor publicly affiliated with 111° West Capital. Fund I’s July 16, 2021 primary Form D names him managing member of the issuer’s general partner; this historical filing does not establish a separately verified current statutory manager office. His current own professional profile describes healthcare software investing. TigerConnect’s current leadership biography identifies him as co-founder and chief medical officer, a board-certified orthopedic surgeon and fellow of the American Academy of Orthopedic Surgeons. He previously founded Specialty Surgical Center and Cardo Medical, sold in 2005 and 2011 respectively. His named native TigerConnect portrait was identified but publisher retrieval is blocked, so no substitute image is supplied.

Michael Matly is a physician-trained healthcare software investor and co-founder/managing partner of 111° West Capital. The manager’s March 31, 2026 Form ADV identifies him as its statutory managing member. Orexo’s 2022 own nomination biography documents an MBA from Harvard Business School, medical doctorate from Mayo Clinic College of Medicine and Cornell BS. His earlier career includes Montreux Growth Partners and Mayo Clinic business development and investments. His own current professional profile confirms the 111° West affiliation and healthcare software focus. Orexo board service is historical: its 2024 AGM notice says he declined reelection. No present Orexo board appointment or personal investment check is inferred.

Sean Cunliffe is a Birmingham-based investment-team member of450 Ventures, the corporate venture arm of Blue Cross and Blue Shield of Alabama. His own public professional profile identifies his affiliation and investment work, and his own2025 Codoxo funding commentary confirms450 Ventures increased its investment in generative-AI healthcare payment integrity. He has also publicly described450 Ventures’ collaboration with Greens by Xplosion Technology on adolescent and young-adult diabetes technology. A precise current managerial rank, appointment day and complete career chronology are not independently verified here. He is distinct from the Canadian biotechnology executive with the same name.

John, with over 20 years of experience in Irish and international financial services, currently serves as a Senior Adviser in Corporate Finance at Key Capital. His expertise spans corporate finance, corporate lending, debt restructuring, and equity investment. John has a proven track record in strategy development, team leadership, and managing complex transactions, demonstrating strong commercial and financial acumen. He has held notable roles at Key Capital, Allied Irish Banks, and other major financial institutions, contributing significantly to their strategic and financial initiatives.

Pat has a diverse professional background with 30 years’ experience in project management, contract management, and negotiation. Currently serving as Services Director at Secure-All Security Group and Investment Manager at FGP Holdings Ltd., Pat has 6 years’ experience as an angel investor focusing on medtech but also in fintech, energy and cleantech, reflecting his interests in multiple sectors. Pat holds a BE in Electronic Engineering from University College Galway and an MBA from OU Business School.

Colin is former chair of the Medtech Syndicate and boasts over 20 years of senior leadership experience in various sectors and regions. His skills include business transformation, startup leadership in Ireland and Asia, and operational excellence. Colin has a PhD from the University of Zurich, a BSc from University College Galway, and is a certified Qualified Person. His career includes significant roles at Abbott, Pfizer, Allergan, and Novartis, reflecting his extensive experience in the medical field.

Bridget is a seasoned finance and strategy corporate executive with nearly 30 years of professional experience. Her areas of expertise include Life Sciences, AI and Automation. Bridget's career encompasses various global roles, including former Chief Financial Officer of a global AI and Automation group, financial advisory on transactions, exit and liquidity events, fundraising, growth and value creation strategies in addition to financial management. Bridget has held board member positions in multiple companies. She is a Chartered Director(IoD, London), a Fellow Member of the Association of Chartered Certified Accountants (FCCA) and holds a diploma in Company Direction.

Yvan has extensive experience in the Life science & business angel industry. He is the founder of TAHO, where he invests in and coaches early-stage startups. Former entrepreneur, Yvan now serves as an independent board member to various startups & scale-ups in Europe, focusing on sectors like MedTech, Ed-Tech & SaaS. His background includes former operational roles in Pharma/MedTech, Biopharma, and company director. As a company director, he facilitated various activities such as equity fund raising, start-up acquisition, executive team overhaul, and company liquidation.

Sam Lapine announced a summer legal internship with bundleIQ focused on AI, intellectual property and product strategy. His own announcement thanks Eric Berkowitz and Nicholas Mohnacky. This is a historical internship affiliation, with no current employment claim.

Chris Klug announced joining bundleIQ as VP of Sales in a public professional post reshared by CEO Nicholas Mohnacky. The announcement establishes the affiliation; an exact present-day tenure and authentic bound portrait were not independently established.

Eric Berkowitz's own Forbes Business Council profile identifies him as bundleIQ's president and partner. He founded Humble TV and co-founded Singtrix and Drumscape. His professional profile supplies a named portrait; his personal companies page separately lists bundleIQ.

Jeff Robbins identifies himself as a bundleIQ co-founder on his own Jeff52 brain-health and learning website. His site publishes a named personal portrait. His exact current operating responsibilities and tenure dates are unpublished.

Andres Espinosa is bundleIQ's technical co-founder and CTO. His own professional profile uses Espinosa; eMerge's January2026 interview spells the surname Espinoza. The2023 founder interview names him as technical co-founder, and his Cursor community event identifies the CTO affiliation.

Nicholas Mohnacky co-founded bundleIQ and leads it as CEO. Organizer eMerge Americas identifies him in its January2026 interview on AI knowledge graphs; his firsthand2023 interview describes the company's AI knowledge assistant and Florida Opportunity Fund backing.

Holden Neer is publicly identified by Neer Venture Partners founderBrianNeer as a technical due-diligence contributor assessing Rasyn’sAIchemistry technology and portfolio work involvingSiPhoxHealth,Adaptyv andMaverickX. The founder calls him achemicalengineeringgraduate student. His own primary profile andPrincetonNuEnergy’s publicinternintroduction confirm ChemicalEngineeringMSstudy atColumbiaUniversity, aNanoEngineering bachelor’sdegree atUCSanDiego, and battery/electrochemistry/nanomaterials research with silicon-based compositeanodes. These facts identify the namedtechnical contributor; they do not establish investmentpartnership, salariedemployment, a completedColumbiaMSdegree, personalchecks or exactappointmentdates. A genuine caption-boundpublicheadshot was not verified; no syntheticportrait substituted.

Brian G. Neer is founder and chiefinvestmentofficer of Neer Venture Partners, an exact identity corroborated by the official biography, FloridaLLC statutorymanager record and FINRA2522448 report. He spent roughly30years onWallStreet focused oncredit, derivatives and dealstructuring, including a23yearMorganStanley career. His own biography names leadership of derivatives/structuredproducts, XVA/corporatederivatives trading, Europeancredit and creditderivativeproducts businesses; he previously foundedCournotCapital. He holds aBSinFinance fromRutgersCollege and anMBAinFinance/StrategicManagement fromWharton. The current ownsite describes sevenyears of earlystage investing and approximately70investments as biography figures, not a claim that every historic personalcheck belongs to the2023manager. Founder primary posts confirm currentAI/deeptech portfolio diligence and support for entrepreneurs.

Mark Morgan is publicly listed by Elkstone as Real Estate Investment Manager. This is an affiliated real-estate platform role; own real-estate footer distinguishes unregulated Elkstone Capital Partners Limited from regulated Elkstone Private Advisors Limited.

Jack Fox is publicly listed by Elkstone as Real Estate Structure Finance Manager. This is an affiliated real-estate platform role; own real-estate footer distinguishes unregulated Elkstone Capital Partners Limited from regulated Elkstone Private Advisors Limited.

Simon English is publicly listed by Elkstone as Real Estate Planning Director. This is an affiliated real-estate platform role; own real-estate footer distinguishes unregulated Elkstone Capital Partners Limited from regulated Elkstone Private Advisors Limited.

Peter Sproule is publicly listed by Elkstone as Real Estate Design Director. This is an affiliated real-estate platform role; own real-estate footer distinguishes unregulated Elkstone Capital Partners Limited from regulated Elkstone Private Advisors Limited.

Aidan Durkin is publicly listed by Elkstone as Real Estate Director of Finance and Operations. This is an affiliated real-estate platform role; own real-estate footer distinguishes unregulated Elkstone Capital Partners Limited from regulated Elkstone Private Advisors Limited.

Jeremy Debono is publicly listed by Elkstone as Senior Venture Investment Associate. Elkstone is an Irish private-market investment platform spanning venture capital, wealth and alternative investment services. The role is verified from its current own directory; exact appointment date and further career details are not independently established here.

Cillian Sugrue is publicly listed by Elkstone as Venture Associate. Elkstone is an Irish private-market investment platform spanning venture capital, wealth and alternative investment services. The role is verified from its current own directory; exact appointment date and further career details are not independently established here.

Ruth Skehan is publicly listed by Elkstone as Venture Operations. Elkstone is an Irish private-market investment platform spanning venture capital, wealth and alternative investment services. The role is verified from its current own directory; exact appointment date and further career details are not independently established here.

Dara O'Shea is publicly listed by Elkstone as Senior Venture Investment Associate. Elkstone is an Irish private-market investment platform spanning venture capital, wealth and alternative investment services. The role is verified from its current own directory; exact appointment date and further career details are not independently established here.